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ULTRASTRUCTURAL STUDIES OF CELL MEMBRANE-ASSOCIATED 
EVENTS IN EARLY AND LATE STAGES OF 
BOVINE CORONAVIRUS REPLICATION
The early events in the in fec tion  of human recta l tumor ce l ls  by 
bovine coronavirus were investigated by immunoelectron microscopy and 
by studies with lysosomotropic weak bases. Virus pa rt ic les  labeled 
with co llo ida l gold were endocytosed by synchronously infected ce lls  
and accumulated in vacuoles that resembled secondary lysosomes. Sites 
o f fusion between the v irus envelope and the plasmalemma were observed 
but fusion events along in t ra c e l lu la r  membranes were not found. 
Exposure o f ce l ls  to ammonium chloride or to methylamine during the 
f i r s t  hour o f in fec tion  had l i t t l e  in h ib ito ry  e ffec t on the production 
o f in fectious v irus . Chloroquine treatments were in h ib ito ry  but th is  
e ffec t was found to resu lt  from re la t iv e ly  la te  events in the 
in fectious process. These studies indicate tha t an acid ic 
in t ra c e l lu la r  compartment is not required fo r  in fectious entry by 
bovine coronavirus. Bovine coronavirus appears to penetrate the host 
ce ll ba rr ie r  by d irec t fusion with the plasmalemma. Consistent with 
th is  in te rp re ta t ion , analyses o f the cu lture environment conducive to 
virus-induced ce ll fusion revealed that the coronaviral fusion fac to r 
was active at a lka line  pH leve ls .
V ira l components were responsible fo r  the induction of
xi i i
cel 1 - to -c e l1 fusion. Immunoelectron microscopy was used to demonstrate 
tha t v ira l  antigens were expressed in the plasma membrane o f infected 
c e l ls  despite the in t ra c e l lu la r  mode fo r  assembly o f th is  v irus . 
Cytopathic expression of the v irus in ce ll monolayers produced tu rb id  
plaques. Scanning electron microscopy was used to characterize ce lls  
tha t remained in these plaques a f te r  the ly s is  o f c e l ls  susceptible to 
the v irus.
xiv
CHAPTER I :  INTRODUCTION
In fection by bovine coronavirus (BCV) is  a primary v ira l  cause of 
neonatal bovine diarrhea. Substantial weight losses and m o rta lity  as 
high as 24% among newborn calves account fo r  the economic impact o f 
th is  syndrome (54).
BCV is a member o f the Coronaviridae, a monogeneric family o f 
large enveloped RNA viruses. Coronaviruses were f i r s t  defined as a 
separate group in 1968 la rge ly  on the basis o f shared v ir io n  morphology 
and antigenic re la tionships (150). Later studies have shown that 
coronaviruses also are distinguished by a unique transcr ip t iona l 
strategy (127), an exclusively in t ra c e l lu la r  v ira l  morphogenesis (125), 
and by envelope glycoproteins with novel features (137).
Although the BCV s tra in  o r ig in a l ly  described by Mebus (95) has 
been adapted to rep lica te  in various ce l l  cu ltures, the host ce ll range 
of other BCV stra ins is quite re s tr ic te d .  Many o f these stra ins can be 
propagated in the adenocarcinoma-derived ce ll l in e  HRT-18 (145). This 
l in e  shares a va r ie ty  o f morphological charac te ris t ics  with absorptive 
in tes t in a l e p ith e lia l c e l ls ,  the natural host ce l ls  o f  BCV in enteric  
in fections (33, 34). HRT-18 ce lls  and other l ines  have been used 
previously in morphological studies o f BCV replicaton (144) but 
important aspects o f the m u lt ip l ica t io n  process remain unclear.
In the present investigations our aim was to analyze morphogenetic 
aspects of the membrane-associated events o f BCV rep l ica tion  in 
cultured c e l ls .  The investigations addressed four spec if ic  objectives:
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1. study and characterize the c e l lu la r  processes and v ira l  functions 
involved in BCV uptake
2. demonstrate and loca lize  v iru s -sp e c if ic  antigens on the plasma 
membrane o f ce l ls  infected with BCV
3. analyze the conditions required fo r  BCV-induced polykaryocytosis
in BFS ce l ls
4. study the morphologic characteris tics  o f BCV-induced plaques in 
HRT-18 c e ll  monolayers.
Following a review o f the pertinent l i te ra tu re ,  the succeeding 
chapters o f th is  d isse rta tion  w i l l  describe the experiments conducted 
to rea lize  the spec if ic  objectives. Each chapter is  organized as a 
self-contained report fo r  submission to a s c ie n t i f ic  jou rna l. The 
manuscripts and journal to which they were submitted are as fo llows:
1. "Immunogold analysis o f the early events in bovine coronavirus
in fec tion  o f cultured c e l ls . "  Submitted to Journal o f  V irology.
Co-authored by J. Storz and W.G. Henk.
2. "Bovine coronavirus antigens localized in the plasmalemma o f
infected c e l ls " .  For submission to Journal o f General Virology.
Co-authored by J. Storz and W.G. Henk.
3. "Analysis o f ce ll fusion induced by bovine coronavirus". For
submission to Archives o f Virology. Co-authored by J. Storz.
4. "Scanning electron microscopic characterization o f bovine 
coronavirus plaques". For submission to Virus Research. 
Co-authored by W.G. Henk and J. Storz.
CHAPTER I I :  REVIEW OF THE PERTINENT LITERATURE
I I .A .  COMPARATIVE PROPERTIES OF CORONAVIRUS STRUCTURE.
Eleven coronaviruses were recognized as members o f the family 
Coronaviridae in the Third Report o f the Coronavirus Study Group o f the 
Vertebrate Virus Subcommittee, the In ternational Committee on Taxonomy 
o f Viruses (124). These agents were id e n t i f ie d  as avian in fectious 
bronch it is  v irus (IBV), human coronavirus (HCV), murine hepa tit is  v irus 
(MHV), bovine coronavirus (BCV), transmissible gas tro e n te r i t is  v irus 
(TGEV), hemagglutinating encephalomyelitis v irus (HEV), canine 
coronavirus (CCV), fe l in e  in fectious p e r i to n i t is  v irus (FIPV), ra t 
coronavirus (RCV), turkey coronavirus (TCV), and porcine epidemic 
diarrhea v irus (PEDV).
I I . A . I .  V ir ion  morphology. The d is t in c t iv e  v ir io n  morphology of 
the coronaviruses was o r ig in a l ly  a primary taxonomic ch a rac te r is t ic  o f 
the group and is s t i l l  used widely fo r  ten ta tive  id e n t i f ic a t io n  (50).
In negatively stained preparations examined with the transmission 
electron microscope, coronaviruses appear as moderately pleomorphic 
p a rt ic les  60-220 nm in diameter. Widely spaced, club-shaped peplomers 
project about 20 nm from the p a r t ic le  surface and produce the "corona" 
appearance fo r  which the v irus is  named (125).
The peplomers of IBV are composed o f two or three copies each of 
a p a ir  o f high molecular weight glycoproteins (17). MHV peplomers also 
consist o f a pa ir o f high molecular weight glycoproteins although the 
number o f proteins per peplomer structure has not been determined 
(136). Among the coronaviruses, there are c le a r ly  discerned
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morphological differences in the peplomers (26, 45). Furthermore, the 
v ir ions  o f HEV (45), BCV (10), and MHV s tra in  DIVIM (140, 141) 
reportedly have two d i f fe re n t  types o f surface projections. The two 
peplomer types o f BCV v ir ions  appear to be func t iona lly  d is t in c t .  King 
et a l . (63) used bromelain to digest the large bulbous peplomers from 
BCV v ir io n s . This treatment l e f t  a short fr inge o f projections around 
pa rt ic les  and enhanced th e ir  hemagglutinating a c t iv i t y .  Trypsin 
treatment produces BCV v ir ions  with shorter peplomers (135). This 
preparation appears to enhance v ira l  in fe c t iv i t y  (130).
Internal components o f the v ir io n  ty p ic a l ly  are not apparent in 
negatively stained preparations. Bingham and Almeida (7), however, 
found tongue- or flask-shaped structures w ith in  IBV v ir ions  that were 
fixed in formaldehyde or treated very b r ie f ly  with the detergent NP40. 
The in ternal component was apparently contiguous with the outer 
envelope. From the data, these workers proposed a morphological model 
fo r  IBV which was supported by la te r  studies of Lamontague et a l . (77) 
who also extended the model to include BCV, HEV, and TGEV.
Internal structures have been described more frequently in th in  
sectioned coronavirions (125). Some investigators have described the 
coronaviral pa rt ic les  as two concentric membranes spaced by a clear 
zone that encirc le  a central core o f variable density (25, 105). The 
inner shell may correspond to the flask-shaped in ternal component of 
Bingham and Almeida (7). Others have described in ternal 
doughnut-shaped or tubular strands in v ir ions  (50, 60). These images 
were interpreted as representing the v ira l  nucleocapsid. In some
instances, electron microscopy o f budding v ir ions  in th in  sections 
suggests tha t the nucleocapsid symmetry is  he lica l (91).
Purif ied coronavirions may be disrupted with nonionic detergents 
to release ribonucleoprotein cores or subviral p a rt ic les . These 
structures were isolated a f te r  detergent treatment in the cases of 
coronaviruses TGEV (42), HEV (108), MHV (139), and HCV 229E (14, 60). 
Nucleocapsid structures may be isolated in density gradients at a 
higher density than in ta c t v ir io n s . In sucrose, v ir ions  band at 1.18 
g/ml whereas nucleocapsids band at approximately 1.27 to 1.28 g/ml 
(125). These nucleocapsid structures have been found to contain large 
amounts o f the nucleocapsid protein o f 50-60K and small amounts o f the 
small envelope g lyprote in , El (136). Sturman and coworkers (139) 
presented evidence tha t El is  an RNA-binding prote in . Electron 
microscopy o f the subviral pa rt ic les  reveals nucleocapsids as spherical 
cores, 60-70 nm in diameter (42), sometimes containing a 9 nm in 
diameter strand (60). Negative staining o f spontaneously disrupted 
v ir ions  occasionally has revealed h e l ica l,  stranded, or tubular 
in ternal components (14, 81). Evidence fo r  the s truc tu ra l organization 
o f the nucleocapsid is  equivocal because the conformation of th is  
element appears to be susceptible to considerable d is to r t io n .
I I . A . 2. Genome stucture and organization. The v ira l  genome is  
a large, continuous single-stranded RNA molecule tha t is  16 to 21 
kilobases long (50). The genomic RNA o f IBV has a 5' cap structure , a 
3' polyadenylate t a i l ,  and is in fectious (74, 80, 120). The
coronaviral genome contains no s ig n if ica n t re i te ra t io n  of 
oligonucleotides (125).
Coronavirus genomes have been compared by T1 oligonucleotide 
analyses in several studies (136). The investigations detected 
considerable differences between stra ins o f MHV and also among isolates 
o f IBV. The T1 oligonucleotide f inger p r in ts  suggest tha t the 
coronaviruses have high rates o f spontaneous mutation and that the RNA 
genome is  quite variable.
The genetic organization o f coronaviruses MHV (128, 157), TGEV 
(58), IBV (8, 9), and FIPV (27) have been the most c losely studied. In 
each case, the 5' gene, presumably the polymerase, is followed in 
sequence by s tructura l genes fo r  the peplomeric prote in , the matrix 
protein and the nucleocapsid prote in . Nonstructural genes were mapped 
at positions which d i f f e r  among the viruses. A "leader sequence" 
located at the 5' end o f the genome is  fused to  each o f the downstream 
genes to  fa c i l i t a t e  a unique mechanism of discontinuous transcr ip t ion  
(127).
I I . A . 3. Structural proteins. Studies o f coronaviral s tructura l 
proteins revealed a complex d iv e rs ity  among mammalian and especia lly 
avian coronaviruses (125). The reported number of major components has 
ranged from as few as 3 to as many as 16 polypeptides in various 
studies. This varia tion  resulted, in part, from actual differences 
between the gene products among coronaviruses (49, 63, 130) and from 
deviations in components o f  cleavage functions which are affected by 
both c e l lu la r  and v ira l  factors (41). Technical d i f f i c u l t ie s  involving
contamination with host c e l l  components (136) and a r t i fa c ts  induced by 
p u r i f ic a t io n  procedures (21) have contributed to the appearance o f 
d iv e rs i ty  as w e l l .
As these factors were resolved, a pattern o f 3 major prote in 
s truc tu ra l elements was described fo r  MHV-A59 by Sturman and coworkers 
(136). A s im ila r  pattern o f 3 classes o f proteins is  generally 
applicable to most other coronaviruses (16, 17, 62, 82). Differences 
remain in the exact number of proteins, th e ir  molecular weights, and 
th e ir  in te rre la t ionsh ips . The major classes o f proteins are id e n t i f ie d  
as: the peplomer p ro te in (s ), S or E2; the nucleocapsid p ro te in , N; and 
the matrix p ro te in (s ), M.
The large surface peplomers o f the v ir io n  are formed by one or 
two species o f high molecular weight g lycoproteins. Cavanagh (17) 
reported that the S protein of IBV is  a oligomer with an apparent 
molecular weight o f about 354,000 which is  composed o f two 
glycopeptides, SI (90K) and S2 (84K) in equimolar proportions. These 
proteins are noncovalently associated and only S2 is  anchored to the 
v irus envelope. The peplomeric glycoprotein o f MHV (E2) is synthesized 
as a 180K precursor which undergoes maturational cleavage to form two 
subunits (90A and 90B) with identica l e lectrophoretic  m o b il i t ie s  (112, 
136). The large bulbous peplomers o f BCV are composed o f a 190K 
glycoprotein which is normally present as subunits o f 120K and 100K 
(221). BCV has an additional high molecular weight g lycoprote in, 
gpl40, which is absent from MHV-A59 (31, 63). This g lycoprote in, a 
hemagglutinin, is  a dimer o f d is u lf id e  linked 65K subunits. Another 
hemagglutinating coronavirus, HEV, also has a high molecular weight
glycoprotein, gpl30/74, in addition to i t s  peplomeric glycoproteins 
( 10).
The N protein is  a nonglycosylated RNA binding prote in with a 
molecular weight o f  50-60K (125). This nucleocapsid protein is 
phosphorylated by a serine kinase that is  v ir io n  associated (123). The 
id e n t i ty  o f the kinase protein i t s e l f  has not been determined and the 
function o f N protein phosphorylation is obscure. Sturman et a l . (139) 
found tha t the matrix prote in , El, o f MHV binds s p e c if ic a l ly  with the 
RNA component o f the nucleocapsid rather than with the N prote in .
The coronavirus M protein is an envelope glycoprotein o f 20 to 
30K molecular weight with 1 to 4 additional polypeptides o f s im ila r  
size (136). The additional polypeptides probably represent 
g lycosylation isomers, at least in the cases o f MHV (114), IBV (15), 
and BCV (31, 78). The M protein o f MHV is  la rge ly  buried in the v ira l  
envelope by three successive membrane spanning helices followed by a 
carboxy-terminal random co il  embedded in the inner face o f the v ir io n  
membrane (118). The matrix proteins o f MHV (103) and BCV (122) bear 
0-1 inked oligosacccharides whereas TGEV (86) and IBV (132) matrix 
proteins have only N-linked oligosaccharides.
I I . A . 4. Envelope properties. The l ip id  composition o f the v ira l  
envelope roughly corresponds to the composition o f the membranes o f the 
c e l ls  in which i t  was propagated (68, 136). The envelope o f TGEV 
contains less cholesterol and fa t ty  acid than is  present in the plasma 
membrane and therefore may more nearly re f le c t  the composition o f 
in t ra c e l lu la r  membranes where budding takes place (136).
A lte rn a t ive ly ,  the acyl side groups and hydrophobic intramembrane 
regions o f the envelope proteins may se lec t ive ly  enrich or deplete 
membrane components before virus envelopment. Cell-derived 
glycosaminoglycans are associated with the external surfaces o f the 
envelopes o f TGEV (42) and MHV-A59 (139). Virion-associated 
glycosaminoglycans are p o te n tia l ly  important in a lte ra t ions  o f many 
v ira l  functions.
I I .B .  ENTRY OF ENVELOPED VIRUSES INTO ANIMAL CELLS.
I I . B . l .  C e llu la r adsorption o f v irus . The i n i t i a l  step in virus 
entry is  attachment of the v ir ions  to  the host c e l ls .  This attachment 
involves recognition and binding o f a c e l lu la r  receptor by a v ira l  
attachment prote in . In enveloped viruses, glycoproteins o f the spikes 
or peplomers apparently f u l f i l l  th is  attachment function (68).
MHV-A59 pa rt ic les  competed with pu r i f ied  peplomeric glycoprotein (E2) 
fo r  v ira l  receptors on the ce ll surface (136). Furthermore, monoclonal 
antibodies against the peplomeric proteins o f MHV-JHM indicated that 
the 170K glycoprotein o f th is  s tra in  is the v ira l  attachment protein 
(20). These studies demonstrate that the high molecular weight class 
o f coronaviral glycoproteins mediates adsorption o f the v irus. 
Attachment o f MHV-A59 to L ce lls  occurs read ily  at 4°C and more quickly 
at 37°C (72). Patterson and Macnaughton (106) employed scanning 
electron microscopy to study the morphological charac te r is t ics  o f HCV 
adsorption to  cultured c e l ls .  The coronavirions were i n i t i a l l y  
attached over the whole ce ll  surface but rap id ly  were red is tr ibu ted  
away from the ce ll periphery by an energy dependent mechanism.
A related v ira l  function, adsorption to erythrocytes, is  
responsible fo r  the phenomena o f hemagglutination and hemadsorption. 
Coronaviruses tha t agglutinate erythrocytes include some s tra ins  o f BCV 
(121), HEV (46), IBV (22), HCV-0C34/43 (59), and MHV-3 (142). HEV 
adsorption to avian erythrocytes is  mediated by binding s ites  at the 
t ip s  of the peplomers (97). Cells infected with hemagglutinating 
enveloped viruses ty p ic a l ly  adsorb erythrocytes to the c e ll  surfaces.
I t  is  unclear, in the case of BCV-infected c e l ls ,  whether the 
erythrocytes adsorb to  v ira l  hemagglutinins in the plasma membrane 
(hemadsorption) or to accumulated v ir ions  at the ce ll  surface 
(pseudohemadsorption) (94).
I I . B . 2. Envelope fusion and nucleocapsid release. The adsorbed 
virus must overcome membrane barriers  during the entry process to 
accomplish nucleocapsid release and in fec t ion . Animal viruses e ffe c t 
nucleocapsid release by fusion o f the v ira l  envelope with a ce ll 
membrane (126). Membrane fusion is  catalyzed by v ira l  envelope 
proteins which function at pH optima tha t are cha rac te r is t ic  o f the 
p a r t icu la r  virus (160). Two separate pathways, d ire c t  and endocytic, 
are recognized fo r  the entry o f animal viruses in to  host ce l ls  (79).
The d ire c t pathway fo r  entry involves fusion o f the v ira l  
envelope with the plasma membrane. This route is  taken by a l im ited  
number o f viruses, p r im arily  members of the paramyxovirus (38, 109) and 
herpesvirus (38) groups, with fusion proteins that are active at 
physiological pH.
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The endocytic route appears to be a more commonly used route fo r  
v irus entry. Studies have indicated that togaviruses (47, 48), 
bunyaviruses (43), retroviruses (3, 110), orthomyxoviruses (92) and 
rhabdoviruses (55) e ffec t entry by th is  in d ire c t route. A widely 
accepted model has been developed fo r  v irus entry by the endocytic 
pathway (88). According to  the model, these viruses are unable to 
enter d i re c t ly  at the plasma membrane because th e ir  fusion proteins are 
fusogenic only in low pH conditions. The adsorbed virus p a rt ic le s , 
therefore, are in terna lized by adsorptive endocytosis, a c e l lu la r  
process fo r  the uptake o f receptor-bound nonphysiological ligands. In 
th is  process, the receptor-bound virus p a rt ic les  are collected in 
c la th r in  coated p i ts ,  sequestered in coated vesicles and delivered to 
prelysosomal structures known as endosomes. The coated vesicles and 
endosomes contain an electrogenic ATP-dependent proton pump (40) that 
creates the acid ic conditions found in the vacuole lumen (149). The 
acid ic environment induces v ira l envelope fusion with the vesicle 
membrane, and the virus nucleocapsid is  released in to  the cytoplasmic 
sap.
This model is  based p r im arily  on two apparently related 
observations. F irs t ,  experiments with lysosomotropic weak bases 
indicate that in fection  by the endocytic pathway involves v irus passage 
through an acid ic c e l lu la r  compartment. The bases which include 
chloroquine, amantadine, ammonium chloride, and methylamine accumulate 
in acid ic compartments o f the ce ll and increase the pH level o f those 
compartments (93, 104). This treatment in h ib its  an early stage of 
v irus rep lica tion  and g rea tly  reduces virus production (47, 48).
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Viruses susceptible to th is  type of in h ib it io n  are those unable to 
enter the ce ll by d ire c t fusion (47).
Secondly, i t  was observed tha t b r ie f  exposure to low pH 
conditions can t r ig g e r  induction of ce ll to ce ll fusion by many 
viruses. Semliki fo rest v irus (48, 158) and fowl plague v irus (92) 
t r ig g e r  ce ll fusion only at low pH, and they require an acid ic 
compartment fo r  entry as w e ll.  In fa c t,  Helenius et a l . (158) found 
tha t a chloroquine-imposed block on Semliki fo res t v irus in fec tious 
entry can be overcome by inducing v irus fusion at the plasma membrane 
with low pH treatments. Furthermore, mutants of Semliki fo rest virus 
were generated that d isplay a lte ra tions in th e ir  s e n s i t iv i ty  to 
lysosomotropic agents and corresponding differences in the pH threshold 
required fo r  induction o f ce ll to ce ll fusion (61). These f ind ings, 
which are incorporated in the model, indicate that the requirement fo r  
an acid ic compartment fo r  virus entry is re lated to the possession of 
pH dependent fusion proteins.
I I . B . 3. Genome uncoating. Uncoating involves the topological 
removal o f envelopes and capsids to enable the v i ra l  nucleic acids to 
in te rac t with ribosomes or polymerases. The la s t  step in uncoating is 
the d issociation o f protein from the nucleic acid. Specific 
information about uncoating of the coronavirus genome has not been 
reported. On the basis o f the data available on other pos it ive-s trand 
RNA viruses, Wilson (162) suggested tha t nucleocapsid disassembly is a 
cotranslational "event". According to th is  hypothesis, the fo llow ing 
steps are involved. V ira l nucleocapsids arr ive  more or less in tac t
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w ith in  the cytoplasm o f infected ce lls  but with some struc tu ra l 
changes. The encapsidated RNA is therefore at least p a r t ia l ly  
protected from attack by ubiquitous c e l lu la r  RNAses. Ribosome binding 
to  an exposed 5' leader sequence and subsequent translocation lead to 
sequential disassembly o f the nucleocapsid. The early  gene product, 
RNA-dependent RNA polymerase may then bind to the 3' end o f the genome 
and, possibly, in i t ia t e  disassembly in the 3' to  5' d ire c t ion .
I I . B . 4. Modes o f coronavirus entry. Few detailed studies o f 
coronavirus entry and uncoating have been performed. Although electron 
microscopic studies generally have indicated tha t coronaviral entry is 
by means of endocytosis (25, 72, 107), other investigators have 
suggested tha t coronaviruses enter the ce l l  by fusion with the ce ll 
membrane (18, 34). Krzystyniak and Dupuy (72) presented k in e t ic  data 
ind ica ting  tha t MHV-3 uptake by macrophages is  time- and 
temperature-dependent and tha t the process is  insensit ive  to in h ib ito rs  
o f phagocytosis.
The e ffec ts  o f lysosomotropic agents on murine coronaviruses have 
been examined in several studies. Malluci (86) reported in 1966 that 
macrophages treated fo r  long periods with chloroquine before MHV 
in fec tion  produce markedly less v irus than untreated c e l ls .  More 
recenty, the e ffects  o f ammonium chloride and chloroquine on MHV-3 
in fec tion  o f L ce lls  was examined (73). At very low m u l t ip l ic i t ie s  o f 
in fec t io n , MHV production at 18 to 24 h post in fec tion  was inh ib ited  by 
these agents. Mizzen and coworkers (98), examined more c losely the 
e ffec ts  o f ammonium chloride on MHV entry. Their work indicated tha t
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the drug suppresses the u ltimate number o f ce l ls  infected by 
attenuating the uncoating process rather than by imposing an absolute 
block on in fec t ion . Although most o f the evidence availab le supports 
an endocytic route o f entry fo r  murine coronaviruses, d e ta i ls  o f the 
uptake mechanism are unclear. This statement is  p a r t ic u la r ly  true fo r  
coronaviruses such BCV which have poorly characterized membrane fusion 
prote ins.
In addition, recent investigations (153) have revealed tha t host 
ce l l  charac te r is t ics  can play a decisive ro le  in the success of virus 
entry. These investigators described a defective entry process in ra t  
g l ia l  C6 c e l ls  that renders them res is tan t to in fec t ion  by MHV-JHM and 
MHV-A59. This defect apparently involves a re s tr ic te d  entry mechanism 
because v irus introduced in to  the c e lls  by polyethylene glycol fusion 
rep lica tes successfully and is released. Subsequent spread o f the 
progeny virus in the C6 monolayer is  inh ib ited  by fusion resistance.
I I .C .  SUBSEQUENT EVENTS IN CORONAVIRUS REPLICATION.
I I . C . l .  Events in  primary tra n s la t io n . RNA-dependent RNA 
polymerase is  not found as part o f the coronavirion but enzyme a c t iv i t y  
can be detected in coronavirus-infected ce lls  (30, 83). Presumably, 
the incoming coronavirus genome serves as messenger RNA fo r  the 
synthesis o f the RNA-dependent RNA polymerase. The protein products of 
th is  primary trans la t ion  are not detected in infected c e l ls  p r io r  to 
t ra n sc r ip t io n .  C e ll- free  trans la tion  of v ir io n  RNA resu lts  in the 
synthesis o f two putative polymerase gene products (29), one o f which 
was id e n t i f ie d  in infected ce lls  labeled at la te  times a f te r  in fec t ion .
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I I .C .2. Synthesis o f  mRNAs and progeny genomes. The
RNA-dependent RNA polymerase transcribes the v ira l  genome in to  a 
fu l l - le n g th  negative strand RNA (76). This species serves as the 
template fo r  synthesis o f genomic-sized mRNA and a group o f 5 or 6 
subgenomic mRNAs, depending upon the p a rt icu la r  coronavirus (27, 58, 
127, 128). Oligonucleotide mapping revealed tha t the mRNA structures 
form a nested set with 3' coterminal ends extending d i f fe re n t  lengths 
in the 5' d irec tion  (133). Coronavirus subgenomic mRNAs are generated 
by a fusion o f non-contiguous nucleic acid sequences during mRNA 
synthesis (75, 127). A "leader sequence" is  transcribed from the 3' 
end of the negative strand RNA and the nascent RNA often dissociates 
from the template. Free leader RNA can rebind to  the template at the 
in i t ia t io n  s ites  o f the various mRNAs and serve as a primer fo r  
continued transc r ip t ion  (85). A recent analysis revealed a temporal 
regulation fo r  the d i f fe re n t ia l  synthesis o f subgenomic mRNAs and 
genomic RNA in ce lls  infected with BCV (59a). The frequency o f 
transcr ip t ion  of each mRNA species appears to be regulated by the 
number o f homologous nucleotides at the intergenic binding s i te  (75).
I I .C .3. Protein synthesis and posttransla tion modifications.
Only the "unique" 5' proximal gene o f each mRNA is  translated. 
Coronavirus mRNAs apparently are func tiona lly  monocistronic and most do 
not d irec t the synthesis o f polyprotein precursors, in contrast to 
other positive-strand RNA viruses. The nucleocapsid protein and the 
nonstructural proteins are synthesized on free ribosomes (122,134).
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The N protein of MHV-JHM is  synthesized as a protein with a molecular 
weight o f  approximately 57,000 (134). This precursor, found 
exclusively in the cytosol, is  phosphorylated immediately a f te r  
synthesis by a serine kinase (120) and associates with the membrane 
frac t io n  as a phosphoprotein with an apparent molecular weight o f 60K 
(125).
The mRNA encoding the peplomeric protein (S or E2) is  translated 
on ribosomes bound to membranes o f the endoplasmic reticulum.
Precursors o f the IBV peplomeric protein possess an N-terminal 18 
amino acid sequence, presumably a membrane insertion  signal sequence, 
tha t is  absent from the mature glycoprotein (8). Oligosaccharide side 
chains o f the peplomeric glycoproteins are attached by 
acetyl glucosamine linkages to asparagine residues o f the polypeptide 
(111, 115). Biosynthesis o f asparagine-linked (N-linked) 
oligosaccharides involves assembly of a precursor form o f the 
oligosaccharide onto a dolichol phosphate l ip id  intermediate, in a 
process sensitive to the a n t ib io t ic  tunicamycin (164). The 
preassembled structure is  transferred en bloc from the dolichol 
molecule to the nascent polypeptide in the c is te rna l space o f the rough 
endoplasmic reticulum. The high mannose N-linked oligosaccharides 
subsequently are converted in the Golgi apparatus to complex type 
oligosaccharides in a sequence of steps involving the trimming o f 
mannose residues and the addition o f other sugars (143). MHV E2 is  
acylated by the covalent addition o f pa lm itic  acid (111, 132). 
P ro teo ly tic  cleavage o f MHV E2, e ithe r by c e l lu la r  proteases acting on 
E2 during virus maturation or by the addition o f a protease to released
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v ir io n s , is  required to activate MHV-induced ce ll fusion (50). The 
fusion o f BCV-infected ce lls  also is  enhanced by the presence of 
tryps in  (135).
The matrix prote in , also sythesized on membrane bound ribosomes, 
d i f fe rs  substan tia l ly  from E2 in  i t s  insertion  and processing.
Although a c e l lu la r  signal recognition p a r t ic le  fo r  membrane insertion 
is  required (117), the matrix proteins o f MHV and IBV possess internal 
rather than o f N-terminal signal sequences (116, 117, 118). In 
contrast to th e ir  peplomeric glycoproteins, the matrix proteins o f MHV 
(115) and BCV (53) are glycosylated pos ttrans la t iona lly  and bear only 
0-1 inked oligosaccharides. These structures were the e a r l ie s t  
discovered v ira l  envelope proteins with 0-1 inked oligosaccharides. The 
0-linked glycosylation process is insensit ive  to tunicamycin treatment. 
The matrix proteins o f TGEV (58) and IBV (132), however, bear N-linked 
oligosaccharides.
I I .C .4. Role o f c e l lu la r  organelles in  coronavirus assembly and 
maturation. Coronaviruses assemble by budding at in t ra c e l lu la r  
membranes, presumably at s ites  defined by the matrix glycoprotein (35, 
91). Assembly involves an in teraction  at the cytoplasmic face of the 
membrane between the v ira l  nucleocapsid and the carboxy terminal 
portion o f the matrix glycoprotein (118, 139). The in t ra c e l lu la r  
location o f the matrix glycoprotein is  re s tr ic te d  to in ternal membranes 
o f the ce ll by an undetermined targeting mechanism (53, 116). I n i t i a l  
budding o f coronaviruses usually occurs at membranes o f the Golgi and 
smooth endoplasmic reticulum (2, 16, 25, 34, 70) but host ce l l  factors
rather than v i ra l  functions determine the in t ra c e l lu la r  compartments 
in to  which MHV buds. For example, the budding o f progeny MHV v ir ions  
in AtR20 ce lls  is  res tr ic te d  to the Golgi cisternae (4), whereas the 
rough endoplasmic reticulum is  a major s i te  o f assembly o f progeny MHV 
v ir ions  in sac(-) ce l ls  (147). In the la t te r  case, the virus pa rt ic les  
are transported through the Golgi apparatus where the envelope proteins 
undergo 0-1 inked glycosylation and f in a l  trimming o f N-linked 
oligosaccharides. The rough endoplasmic reticulum and the Golgi 
vesicles ty p ic a l ly  become d ila ted  with accumulated v irus pa rt ic les  and 
electron-dense g ra n u lo - f ib r i l la r  material (25, 33, 34, 36).
Investigations of the e ffec ts  o f monensin treatment suggest that 
the Golgi apparatus is  also involved in the release o f progeny 
coronavirus from in tac t c e l ls .  Monensin is a sodium ionophore that 
blocks glycoprotein transport to plasma membranes at the level o f  the 
Golgi (143). Nieman and coworkers (102) found tha t monensin treatment 
o f MHV-infected ce lls  prevents 0-linked glycosylation o f the M prote in . 
Budding o f MHV continued in the presence o f the ionophore, but release 
o f the assembled pa rt ic les  was inh ib ited . The ro le  o f lysosomes in 
coronavirus in fec tion  was examined by Ducatelle and Hoorens (36). They 
reported that accumulated coronavirus pa rt ic les  often can be found in 
secondary lysomes at la te  stages o f the in fec t ion . Although lysosomal 
enzymes seemed unable to destroy the accumulated viruses, i t  was 
suggested tha t these structures represent an in t ra c e l lu la r  defense 
mechanism.
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I I .D .  INDUCTION OF CELL FUSION BY ENVELOPED VIRUSES.
I I . D . l .  S ignificance o f ce l l  fusion fo r  cytopathogenesis. The
in fe c t iv i t y  o f an enveloped virus is modulated by i t s  fusion a c t iv i t y  
which is  required both fo r  the i n i t i a l  in fec tion  and fo r  transmission 
o f progeny virus to neighboring c e l ls .  The outcome o f coronavirus 
in fections can be determined by the a b i l i t y  o f the host c e l l  to 
activate the v ira l  fusion fac to r (41). This observation may be 
responsible, in part, fo r  the s tringent requirements o f many newly 
isolated coronaviruses fo r  d if fe re n t ia te d  c e l ls .  Resistance to 
membrane fusion by a p a r t icu la r  host ce ll type can minimize polykaryon 
formation and reduce v irus spread (99). Fusing properties are overt ly  
expressed by a va r ie ty  o f enveloped viruses (69). Induction o f 
polykaryon formation is a cytopathic e ffe c t often s ignaling approaching 
ce ll  death (68). For example, ce ll fusion is  a major fac to r in early 
ce l l  death caused by measles virus (44). Fusion a c t iv i t y  is  probably a 
virulence fac to r in  v ivo . Multinucleated ce lls  are ch a rac te r is t ic  o f 
many coronavirus-induced lesions.
I I .D .2. Events of virus-induced c e ll  fusion. Entry o f an 
enveloped virus in to  i t s  host ce ll involves a membrane fusion event 
that is  catalyzed by v ira l  fusion proteins. Virus fusion with the host 
ce l l  plasma membrane may also occur in an amplified form resu lt ing  in 
the formation of polykaryons (160). Polykaryocytosis is  thought to 
resu lt  from the action o f v i ra l  fusion proteins on the plasma membranes 
o f adjacent c e l ls .  Although th is  phenomenon has long been described,
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the actual molecular events occurring during the fusion process are 
s t i l l  con trovers ia l. Virus-induced polykaryon formation may proceed by 
e ithe r fusion from without (FFWO) or fusion from w ith in  (FFWI) (68). 
FFWO occurs soon a f te r  in fec tion  when massive numbers o f the enveloped 
viruses fuse simultaneously with the plasma membrane of the c e l ls .
FFWI, an event occuring la te  in the in fec t ion , is  catalyzed by fusion 
proteins tha t are expressed at the plasma membrane o f infected ce lls  
(160). Virus-induced ce ll  fusion and the fusion event o f v irus entry 
have d i f fe re n t  e ffec ts  on c e l lu la r  in te g r i ty .  Entry by fusion is  
innocuous in i t s e l f  but ce l l  death u lt im a te ly  resu lts  from the massive 
assault o f virus-induced ce ll  fusion (68).
I I .D .3. pH dependence o f virus-induced ce ll  fusion. Fusion 
a c t iv i t y  o f enveloped viruses is rou tine ly  studied in d ire c t ly  by assays 
o f virus-induced ce ll  fusion. Cell fusion can be induced at 
physiological pH by paramyxoviruses (55) and some stra ins  o f herpes 
simplex v irus (38). The pH-independent fusion a c t iv i t y  o f these 
viruses w i l l  induce FFWO o f appropriate target ce lls  that are infected 
at high m u l t ip l ic i t y .  FFWI occurs spontaneously among 
paramyxovirus-infected cultured ce l ls  fo llow ing expression o f v ira l  
fusion proteins in the plasma membrane (160).
Many other viruses, including togaviruses (47, 158, 159), 
influenza viruses (57, 92, 159), rhabdoviruses (110), re troviruses 
(110), and bunyaviruses (43), have been found capable o f inducing 
fusion o f cultured ce lls  but only at nonphysiological pH. Induction of 
FFWO by these viruses requires tha t high m u l t ip l ic i t ie s  o f v irus be
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adsorbed to the ce ll  surface. The v iru s -ce l l  complex is  then b r ie f ly  
exposed to acid pH and returned to neutral pH to  allow fusion to 
proceed (160). The pH-dependent fusion a c t iv i t y  o f such viruses can 
also be demonstrated by FFWI triggered by acid ic conditions (43, 61, 
110). For th is  purpose, v irus-in fec ted  ce ll monololayers are exposed 
b r ie f ly  to acid ic medium then incubated at physiological pH to allow 
fusion to proceed. The minimum pH level required to induce 
pH-dependent fusion is  cha rac te r is t ic  o f the p a r t icu la r  v irus .
Studies o f pH-dependent v ira l  fusion indicate tha t polykaryon 
formation ensues when a c id i f ic a t io n  activates v ira l  fusion proteins 
tha t are positioned at the plasma membrane (160). The required acid ic 
conditions are hypothesized to mimic the conditions w ith in  endosomes 
where the fusion event o f v irus entry takes place. Virus-induced 
pH-dependent ce ll fusion appears to be a two step process, however. 
Investigations have found tha t although acid ic conditions are required 
to induce fusion o f cultured c e l ls ,  membrane fusion i t s e l f  occurs only 
a f te r  the pH is returned to neutral conditions (37, 87). There is no 
evidence that the pH o f the endosome fluctuates from acid to neutral 
pH.
I I .E .  PERSISTENCE OF CORONAVIRAL INFECTIONS.
I I . E . l .  Chronic demyelinating disease in  rodents. Many 
coronaviruses appear to be capable of inducing chronic in fections in 
animals (125). Chronic demyelination in the rodent central nervous 
system is  an important part o f the disease spectrum that may be 
produced by MHV in fec tion  (67). Hosts o f the appropriate age and
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genetic background inoculated in trace reb ra lly  with high doses o f w ild 
type MHV develop an acute le tha l disease (65, 155). A chronic 
demyelinating disease in mice is produced by low doses o f w ild-type 
virus or high doses o f attenuated temperature-sensitive mutants of 
MHV-A59 or MHV-JHM (71, 154, 156). Koga (67) described the sequence o f 
neuropathological events in chronic demyelinating disease. I n i t i a l l y ,  
c l in ic a l ly  s i le n t  lesions o f acute encephalitis develop which do not 
enlarge fo llow ing a r ise  in neutra liz ing  antibodies. At th is  time, 
demyelinating lesions are found which are characterized by in fec tion  
and ly s is  o f oligodendrocytes with l i t t l e  damage to axons. Previous 
workers reported that mice with MHV-induced demyelination often recover 
with apparent remyelination but develop a pers is ting  or recurring 
demyelination (49). Sorenson and Dales (126a) demonstrated that 
coronaviral RNA persists in Purkinje neurons o f the cerebellum o f rats 
that undergo prolonged in fec tions. These ce lls  may function as v irus 
repositories and provide a reservoir o f in fectious v irus throughout the 
prolonged asymptomatic phase o f MHV-JHM in fec t ion .
Several factors in MHV-induced encephalomyelitis may prevent 
nonfatal in fec tion  and instead cause a nonlethal chronic demyelination 
disease. The emergence o f v ira l  mutants attenuated by altered ce ll 
tropism is implicated. A temperature-sensitive mutant o f MHV-JHM,
(ts -8 ) causes a high incidence o f demyelination with low m orta lity  
(66). The mutant causes selective destruction o f oligodendrocytes and 
p re fe re n t ia l ly  destroys nonneuronal ce l ls  o f the CNS i_n v i t r o  (35). 
Koolen et a l . (71), presented evidence suggesting that tissue tropism 
of another mutant, ts-342, determines res tr ic te d  rep l ica tion  and
attenuated virulence of th is  variant. Replication o f ts-342 was 
re s tr ic te d  to the brain in  vivo and the agent induces subacute 
demyelinating disease. Revertants spread from the brain and cause 
fulminant h epa tit is ,  the apparent cause o f death o f mice infected with 
w ild-type v irus (71). V irus-spec if ic  antibodies seem to play a ro le  in 
the development o f acute or chronic disease. Antibodies were found to 
block the in fec tion  of neurons but not oligodendrocytes (11). Also, 
mutations of the peplomeric protein confer resistance to 
neutra liza tion  by monoclonal antibodies and these v irus variants induce 
a subacute demyelinating disease rather than an acute encephalomyelitis 
(24, 39).
I I . E . 2 Persistence o f coronaviral in fections o f  c a t t le .  The
enteric  coronaviruses, which may cause severe diarrheal disease in 
newborn or in fan t animals, ch a ra c te r is t ica l ly  produce mild or 
inapparent persistent in fections in adults (50). Co llins et a l . (20a) 
found that the incidence o f shedding o f enteric  coronavirus from adult 
c a t t le  increased from 20% to 30% during the la s t two months o f 
gestation to 65% to 70% at p a r tu r i t io n .  Coronavirus shedding at 
p a r tu r i t io n  may resu lt  in immediate exposure o f neonates at an age when 
they are highly susceptible to  in fec tion  with the v irus . The immune 
responses o f c l in ic a l ly  normal cows that chron ica lly  shed bovine 
coronavirus-specific immune complexes was studied by Crouch et a l .
(23). The in fec tion  was not cleared despite the presence o f both fecal 
and serum antibody. Immunosuppression was experimentally induced by 
dexamethasone treatment. The drug temporarily reduced shedding of
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v iru s -sp e c if ic  immune complexes but fu r the r analyses o f th is  e ffec t 
fa i le d  to establish any major ro le  fo r  ce l l  mediated immunity in 
maintaining the chronic in fec t ion .
I I . E . 3. Mechanisms o f coronaviral persistence in  cultured 
c e l ls .  Persistent or inapparent in fections can be described as those 
in which the virus in fects  and k i l l s  only a small percentage o f ce l ls  
in the cu ltu re  (68). Coronaviruses, in contrast to  other 
positive-stranded viruses, tend to establish persistent in fections in 
cultured c e l ls  (125). Possible mechanisms involved in the 
establishment o f pers istent coronaviral in fections include conditional 
interference by emerging temperature-sensitive or poorly growing 
mutants (71), the development o f defective in te r fe r in g  virus (84), and 
the production o f in terferon (5). Baybutt et a l . (6), described the 
production of a long-term persistent in fec tion  established in the 
murine ce ll  l in e  sac(-). A heterogenous co llec t ion  o f 
temperature-sensitive mutants was id e n t i f ie d  among the v irus progeny. 
The investigators argued that the temperature-sensitive phenotype 
i t s e l f  was probably in s ig n if ica n t in the establishment o f the 
pe rs is ten tly  infected cu lture and arose as an "e ffe c t"  rather than a 
"cause" o f persistence. These workers established that low 
m u l t ip l ic i t y  o f in fection  favored the establishment o f persistent 
in fections. Interferon was apparently not involved in maintenance of 
persistence.
The generation o f defective in te r fe r in g  p a rt ic les  by MHV-infected 
cultures was reported by Makino et a l . (84). In the course o f seria l
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undiluted passages o f MHV-JHM virus in ce ll  cu ltu re , they found 
markedly reduced in fe c t iv i t y .  The progeny viruses in te rfe red  with the 
re p l ica t io n  o f the o r ig ina l w ild  type JHM v irus , lacked part o f  the 
v ira l  genome, and possessed other properties o f defective in te r fe r in g  
p a r t ic le s .  Regulation o f a persistent coronavirus in fec t ion  by a host 
c e l l  determinant was examined by Mizzen et a l . (99). MHV-induced 
fusion was markedly reduced in LM-K ce lls  as compared to L-2 c e l ls .  
Their investiga tion  indicated that the inherent resistance o f the LM-K 
c e ll  membrane moderates v irus dissemination and contributes to the 
state o f v irus persistence.
CHAPTER I I I ;  EARLY EVENTS IN BOVINE CORONAVIRUS 
INFECTION OF CULTURED CELLS
I I I .A .  INTRODUCTION.
Bovine coronavirus (BCV) is  a member of the Coronaviridae fam ily 
o f enveloped RNA viruses (125). BCV replica tes in absorptive 
e p ith e l ia l  ce l ls  o f the in te s t in a l t ra c t  in neonatal calves and induces 
serious enteric  disease (54). Although many features o f coronavirus 
re p l ica t ion  in  cultured c e l ls  have been described (25, 36, 70, 73, 97, 
147), the early events o f BCV in fection  remain poorly characterized.
At least two d is t in c t  pathways evidently operate fo r  the entry o f 
enveloped viruses in to  animal ce lls  (79). Some viruses penetrate the 
ce ll by d ire c t  fusion o f the v ira l  envelope with the plasma membrane. 
Paramyxoviruses, fo r  example, fuse d ire c t ly  with the c e l lu la r  plasma 
membrane at physiological conditions (109). Other viruses fuse with 
membranes only under nonphysiological, low pH conditions (47, 109,
159). The second pathway fo r  enveloped virus entry involves c e l lu la r  
uptake by endocytosis (88, 89, 90, 92). The endocytosed v ir ions  travel 
to membrane bound in t ra c e l lu la r  compartments where ac id ic  conditions 
are maintained (40, 149). The low pH o f th is  c e l lu la r  compartment 
apparently fa c i l i ta te s  fusion between the v ira l  envelope and the 
vesicle membrane and resu lts  in release o f the nucleocapsid in to  the 
cytoplasm. In fection  o f cultured ce lls  by a va r ie ty  o f enveloped 
viruses can be blocked with lysosomotropic weak bases (3, 47, 92, 98). 
These bases accumulate in acid ic c e l lu la r  compartments and a l te r  th e ir  
pH (93). The change apparently prevents low pH-dependent v ira l
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envelope fusion with the vesicle membrane and thus block in fec tion  
(48).
Studies of in h ib i t io n  by lysosomotropic agents ind icate an 
endocytic mechanism fo r  the entry o f mouse coronavirus (73, 98, 146) 
but the v a l id i t y  o f th is  experimental approach has recently been 
questioned (13). In order to establish the route o f entry fo r  BCV, we 
examined the early events o f the in fec tion  process not only by 
in fe c t iv i t y  and in h ib i t io n  studies but by immunoelectron microscopy as 
w e l l .
I l l . B .  MATERIALS AND METHODS.
I I I . B . l .  Cells and v irus . Monolayers o f the human recta l tumor 
ce ll l in e  HRT-18 (145) were grown in Dulbecco modified Eagle medium 
(DMEM) containing streptomycin sulphate (0.1 mg per ml), p e n ic i l l in  
(100 units per ml), and 5% fe ta l c a l f  serum. The Mebus s tra in  L9 o f 
bovine coronavirus (121, 131) was propagated in HRT-18 c e l ls .  Virus 
stocks were prepared in ce l ls  infected at a m u l t ip l ic i t y  o f 
approximately 0.01 PFU per c e l l ,  incubated fo r  4 to  5 days at 37°C in 
serum-free DMEM and harvested by freeze-thawing. V ira l t i t e r s  obtained 
in these preparations ranged from 106 to 107 PFU per ml.
I I I .B .2 .  Plaque assays. The in fe c t iv i t y  t i t e r  was assayed in 
HRT-18 monolayers grown in 6-well plates. The monolayers were adsorbed 
with v irus fo r  1 h at 37°C, overlayed with serum-free DMEM containing 
0.6% agarose (Bethesda Research Laboratories) and 4 ug o f tryps in
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(Difco Laboratories) per ml. A fte r 3 days o f incubation at 37°C, 
plaques were counted without sta in ing.
I I I .B .3 .  Virus p u r i f ic a t io n  and concentration. Infected 
cultures were harvested at 4 d post in fec tion  when more than 50% o f the 
ce lls  showed evidence o f v irus in fec t ion . The infected material was 
subjected to two freeze-thaw cycles and sonic d isruption (Ulrasonic 
250; Branson Sonic Power Company) fo r  30 sec on ice to  release the 
v irus . The virus suspension was c la r i f ie d  by cen tr ifugation  at 10,000 
x g fo r  40 min, sedimented at 90,000 x g fo r  2 h through a 20% sucrose 
cushion, and resuspended in DMEM (pH 7.4) buffered with 12 mM HEPES and 
25 mM NaHC03 (uptake medium). The recovery o f in fectious virus ranged 
from 50% to 75%.
I1 I.B .4 . Immunoreagents. Rabbit antiserum to BCV tha t had been 
p u r i f ied  from infected bovine fe ta l kidney c e l ls  was prepared by 
previous investigators in our lab. The antibody level was t i te re d  by a 
plaque neu tra liza tion  te s t .  The IgG fractions o f the antiserum and of 
normal rabb it serum were obtained by protein A-sepharose column 
chromatography. Goat a n t i- ra b b it  antibody (IgG) complexed to 5-nm 
co llo ida l gold pa rt ic les  manufactured by Janssen L ife  Sciences 
Products, Beerse, Belgium was used. For v irus in te rna liza t io n  
experiments, the immunoreagents were d ilu ted  in uptake medium to levels 
producing less than 50% neu tra liza tion  o f v i ra l  in fe c t iv i t y .
I I I .B .5 .  Immunogold labeling o f v irus entry. Cell monolayers, 
grown in 2-well chamber s lides (Miles S c ie n t i f ic ) ,  were rinsed with 
uptake medium, ch i l le d  to 4°C, and reacted with p u r i f ie d  v irus fo r  60 
min at a m u l t ip l ic i t y  o f 50 PFU per c e l l .  The v iru s -c e l l  complexes 
were incubated on ice fo r  45 min with rabb it anti-BCV antibody, washed 
twice with uptake medium, and incubated fo r  45 min with gold-labeled 
goat a n t i- ra b b it  antibody. A fte r washing at 4°C, the c e l ls  were 
rap id ly  warmed to 37°C and incubated fo r  various lengths o f time before 
primary f ix a t io n  at 4°C with 2% glutaraldehyde and 2% formaldehyde in 
0.1 M sodium cacodyl ate buffer at pH 7.4.
I I I .B .6 .  Processing fo r  electron microscopy. The monolayers 
were then fixed fo r  1 h at 25°C in a solution o f 1% osmium te trox ide  
and 1% potassium ferrocyanide in 0.1 M cacodylate buffe r (pH 7.4), 
washed in 0.2 M sodium acetate buffer pH 3.5, and stained en bloc fo r  1
h with 0.2% uranyl acetate in acetate buffe r. A fte r  washing in
d is t i l le d  water, the ce lls  were dehydrated in an ascending alcohol 
gradient, embedded i_n s itu  in a mixture o f Epon and A ra ld ite  epoxy 
resins (100), and polymerized at 60°C. Thin sections were stained with
uranyl magnesium acetate followed by lead c i t ra te  and viewed with a
Zeiss EM-10 electron microscope at 80 kV.
I I I .B .7 .  Effects o f lysosomotropic agents. Monolayers o f HRT-18 
ce lls  were grown in 24-well plates fo r  experiments involv ing treatments 
with lysosomotropic agents. Infection o f HRT-18 c e l ls  by BCV was 
synchronized by temperature s h i f t  to analyze the re la t iv e  e ffec ts  of
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chloroquine, ammonium chloride, methylamine, and amantadine.
Monolayers were washed with medium, ch il le d  to 4°C, adsorbed fo r  60 min 
with BCV at a m u l t ip l ic i t y  o f approximately 3 PFU per c e l l ,  and rinsed 
with cold uptake medium to remove unadsorbed v irus . The monolayers 
were given warm medium with the appropriate lysosomotropic agents and 
transferred to a 37°C incubator. In control monolayers, exposure to 
the agent was delayed u n t i l  1 h post in fec t ion . A l l  cultures were 
harvested a f te r  incubation fo r  20 h at 37°C, and the y ie ld  o f 
in fectious virus was t i te re d  by plaque assays.
The effects  o f various concentrations o f ammonium chloride and 
chloroquine on virus in fec tion  at 37°C was tested on monolayers tha t 
were washed with uptake medium and pretreated fo r  15 min with the agent 
d ilu ted  in uptake medium. The ce lls  were infected with BCV at 37°C fo r  
60 min at a m u l t ip l ic i t y  o f approximately 3 PFU per ce ll  and then fed 
fresh uptake medium. The lysosomotropic agent was present throughout 
the in fec t ion . Exposure to the agent was delayed u n t i l  1 h post 
in fec tion  in control monolayers. A fte r  incubation fo r  20 h at 37°C, 
the cultures were harvested and the y ie ld  o f in fectious v irus was 
t i te re d  by plaque assays.
The time dependence o f in h ib i t io n  by 120 uM chloroquine was 
analyzed by measuring the e ffects  o f increasing delays in chloroquine 
addition. The monolayers were synchronously infected as described 
above except that chloroquine was f i r s t  added to the cultures at 
various times a f te r  rewarming. A fte r  incubation at 37°C fo r  20 h, the 
v irus t i t e r  was determined by plaque assay.
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The pH dependence o f chloroquine in h ib i t io n  was determined with 
monolayers tha t were allowed to bind BCV at 4°C and then were washed 
with cold DMEM. The c e lls  were warmed to 37°C fo r  60 sec by the 
addition o f DMEM buffered with 12 mM HEPES and 12 mM MES at various pH 
levels and given fresh uptake medium with 120 uM chloroquine. 
Chloroquine was added at 1 h post in fec tion  fo r  a f in a l  concentration 
o f 120 uM in a l l  monolayers, and a f te r  a 20 h in fec tion  the v irus t i t e r  
in the cu ltu re  was determined by plaque assay.
I I I .B .8 .  Ind irec t immunofluorescence. Monolayers were fixed fo r  
10 min in 4% formaldehyde, permeabilized fo r  5 min with acetone at 
-20°C, incubated with rabb it anti-BCV antibody, and reacted with goat 
a n t i- ra b b it  antibody conjugated to fluorescein isothiocyanate. The 
preparations were viewed with a Leitz fluorescent microscope using 
epifluorescence. The frac t io n  o f infected ce lls  in each preparation 
was calculated from 5 randomly selected f ie ld s  o f approximately 200 
ce lls  photographed with both phase contrast and fluorescence optics.
I I I .B .9 .  Chemicals. Stock solutions were prepared d a i ly  o f 20 
mM chloroquine-HCl, 200 mM amantadine-HCl, 1.0 M ammonium ch lor ide, and 
4.0 M methylamine (Sigma Chemical Company) in sa line. The solutions 
were adjusted to neutral pH with NaOH, and d ilu ted  in to  uptake medium.
I I I .C .  RESULTS.
I I I . C . l .  Morphologic analysis o f BCV adsorption. Cells 
adsorbed with BCV pa rt ic les  and immunolabeled at 4°C reveal tha t coated
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p i t  formation had ceased leaving a l l  v ir ions  at the c e ll  ex te r io r  
(FIG. I I I . l ) .  The v ir ions  were read ily  id e n t i f ie d  by the associated 
co llo id a l gold p a rt ic le s . The use o f h ighly d i lu te  anti-BCV antibody 
labeled most v ir ions  with only a few gold p a rt ic le s . These pa rt ic les  
were separated from the v ira l  envelope by an average distance o f about 
15 nm. The virus p a rt ic les  usually contained an electron dense core 
and were spherical in shape with diameters ranging from 50 to 80 nm. 
V irions with e l l ip so id a l p ro f i le s  also were observed. The v ira l  
envelope was separated from the plasma membrane by a distance o f less 
than 15 nm in many cases. F ib r i l l a r  connections were evident at the 
plasma membrane attachment s i te  (FIG. I I I .1 A ,  inset) but the peplomer 
structures o f BCV, d is t in c t iv e  in negative sta ins, could ra re ly  be 
distinguished. The number o f v irus pa rt ic les  per ce ll  appeared to 
exceed what would be expected from the input m u l t ip l ic i t y  (50 PFU per 
c e l l ) .  This is  probably because ( i )  the v irus pa rt ic les  were adsorbed 
by only a small m inority o f  HRT-18 ce lls  in the monolayer and ( i i )  many 
o f the virus pa rt ic les  were not in fectious.
I I I .C .2 .  Endocytosis o f BCV at 37°C. Virus pa rt ic les  at 
in t ra c e l lu la r  locations were morphologically less read ily  
distinguished. The associated gold labe l, however, permitted 
id e n t i f ic a t io n  o f the in t ra c e l lu la r  s ites o f v irus p a rt ic les  during 
uptake. A fte r  the BCV-cell complexes were incubated fo r  2 to 5 min at 
37°C, labeled virus pa rt ic les  were evident in coated p i ts ,  coated 
vesicles and in small multiform vesicles with smooth membranes (FIG.
I I I . 2). Coated vesicles had c irc u la r  p ro f i le s  o f 100 nm in diameter,
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FIG. I I I . l .  Immunoelectron microscopy o f BCV in te ra c tion  w ith the
plasma membrane at 4°C. (A) Virus p a rtic le s  are labeled
w ith gold. Envelope projections contact the c e ll membrane 
( in se t, arrowheads). (B) Gold p a rtic le s  fa ile d  to  bind to 
v ir io n s  in preparations incubated w ith normal rabb it serum 
IgG. Bars = 100 nm, inset bar = 50 nm.
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FIG. I I I . 2. Early stages o f BCV in te rn a liz a tio n . Monolayers were
warmed fo r  2 min (A) or 5 min (B,C). Immunogold labeled 
v irus  p a rtic le s  are found in  a coated p i t  (CP) and in 
in tra c e llu la r  vesicles w ith smooth membranes (arrowheads). 
Bars = 100 nm.
whereas the small smooth membrane vesicles were ty p ic a lly  la rge r (160- 
to  300-nm in the greater dimension) and had d iverse ly  shaped p ro file s . 
These early membranous compartments usually contained only one or two 
v irus  p a rtic le s  but had very l i t t l e  empty space and few nonviral 
contents. A fte r 10 to  15 min incubation at 37°C, the in tra c e llu la r  
v ir io n s  accumulated in la rger vacuoles, 400- to  800-nm across (FIG.
I I I . 3 ). These vacuoles contained as many as 10 labeled v ir io n s  
although some degeneration o f p a rtic le  morphology had occurred. The 
large vacuoles also contained unlabeled vesic les, f i b r i l l a r  strands, 
and amorphous m ateria l. These la t te r  contents ind icate  tha t the 
vacuoles may represent secondary lysosomes.
Gold p a rtic le s  were c lose ly associated w ith v irus  structures and 
were separated from the nearest lim it in g  c e llu la r  membrane by distances 
exceeding 20 nm. In a few cases, associations between gold p a rtic le s  
and vesic le  membranes were seen ind ica ting  possible in tra c e llu la r  s ites  
o f fusion (Fig I I I . 3). The presence o f a nearby v ir io n  or e lectron 
dense material made id e n tif ic a tio n  o f the gold binding s ite  ambiguous. 
A fte r rewarming, gold p a rtic le s  were observed at plasma membrane s ites  
d is tan t from adsorbed v ir io n s  (FIG. I I I . 4). Apparent fusion o f the 
v irus envelope w ith the plasma membrane was recorded (FIG. I I I . 5) but 
fusion o f gold labeled v ir io n s  w ith in tra c e llu la r  membranes was never 
observed.
Control experiments were conducted to confirm the sp e c ific  nature 
o f the gold marking o f BCV antigens. Cells w ith surface-adsorbed v irus 
tha t were incubated with normal rabb it IgG instead o f anti-BCV antibody 
were not labeled by the gold probe (FIG. I I I . I B ) .  Furthermore, gold
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I I I . 3. Accumulation o f BCV inside vacuoles. V iru s -ce ll complexes 
were incubated fo r  10 min (A) or 15 min (B,C) at 37°C. 
Electron dense p a rtic le s  associated w ith gold represent 
p a r t ia l ly  degraded v ir io n s . Vacuole contents also include 
unlabeled vesicles (v) and f i b r i l l a r  debris. Note possible 
s ites  o f gold association w ith vacuole membranes 
(arrowhead). Bars = 100 nm.
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FIG. I I I . 4. Association o f gold label w ith plasma membrane a fte r  b r ie f  
rewarming. Possible s ites  o f v ira l envelope fusion w ith 
the plasma membrane are marked by gold p a rtic le s . Bars = 
100 nm.
FIG. I I I . 5. In te rac tion  o f BCV envelope w ith plasma membrane. V irus­
c e ll complexes were rewarmed fo r  (A) 30 sec or (B) 5 min. 
Note s ites  o f apparent fusion marked by arrowheads. The 
v ir io n  depicted in B is  unlabeled because the preparation 
was not incubated w ith immunoreagents. Bars = 50 nm.
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p a rtic le s  were not observed at plasma membrane s ite s  in  the absence o f 
v irus  p a rtic le s  when v iru s -c e ll complexes were immunolabeled and fixed 
at 4°C. These contro ls indicated tha t the immunoreagents s p e c if ic a lly  
marked BCV antigens and not HRT-18 c e ll membranes.
I I I .C .3. E ffec t o f lysosomotropic agents on the y ie ld  o f 
in fec tious  v iru s . We examined the e ffec ts  o f several lysosomotropic 
weak bases on BCV in fe c tio n . These agents a lte r  the pH o f endocytic 
vacuoles and prevent endocytic entry by some other enveloped viruses.
To compare the agents, synchronously infected c e lls  were treated with 
chloroquine, amantadine, ammonium ch loride or methylamine (Table 111.1) 
at concentrations previously found to be e ffe c tive  in  studies o f v irus 
entry (447, 61, 92, 101).
Table I I I . l .  E ffec t o f lysosomotropic agents on BCV in fe c tio n
Virus y ie ld 3
Full
In h ib ito r  (cone, mM) Exposure
Delayed 
Exposure %Reductionb
Ammonium ch loride  (10) 15 (7.02) 23 (7.20) 34
Methylamine (10) 15 (6.53) 24 (6.73) 37
Amantadine (0.5) 5.5 (6.09) 7.0 (5.90) 22
Chloroquine (0.12) 0.1 (3.87) 6.5 (5.72) 99
aVirus y ie ld  lis te d  as percent o f the pos itive  contro l and as 
log PFU per ml ( in  parentheses).
bPercent reduction calculated as (1.0 - [ f u l l  exposure/delayed 
exposure]).
Ammonium ch lo ride , and methylamine at concentrations o f 10 mM 
were re la t iv e ly  weak in h ib ito rs  o f BCV in fe c tio n  when these agents were 
present throughout the in fe c tio n . The presence o f these agents during 
the f i r s t  hour o f in fe c tio n  produced less than a 40% decrease in BCV 
y ie ld . Amantadine was a stronger in h ib ito r  o f the y ie ld  o f in fec tious  
BCV in HRT-18 c e lls . An in h ib ito ry  e ffe c t was also seen in control 
preparations tha t were not exposed to the base during the f i r s t  hour o f 
v irus  re p lic a tio n . Additional exposure to amantadine fo r  the f i r s t  60 
min o f in fe c tio n  resulted in only a 22% drop in v irus y ie ld . Thus, 
only chloroquine, o f the four lysosomotropic agents tested, strongly 
suppressed the early  stages o f BCV re p lica tio n . Infected c e lls  tha t 
were fu l ly  exposed to 120 uM chloroquine from the time o f synchronous 
in fec tion  u n til harvest produced only 1.4% as much v irus  as did 
cu ltures treated with chloroquine from 1 h post in fe c tio n  u n til 
harvest.
We tested the e ffe c ts  o f various doses o f ammonium ch loride  and 
chloroquine on BCV in fe c tio n . Synchronously infected monolayers were 
exposed to the agents at the time o f temperature s h if t  to  avoid drug 
e ffec ts  on the v irus adsorption stage. A second set o f monolayers was 
pretreated w ith the drugs fo r  15 min and infected at 37°C to  insure 
tha t in travacuolar pH leve ls  were a ltered during BCV en try . The 
e ffec ts  o f the agents were s im ila r fo r  both in fe c tio n  protocols. In
synchronously infected c e lls , ammonium ch loride reduced the y ie ld  o f 
BCV by less than 1 log u n it even at 20 mM leve ls (FIG. I I I .6 A ) .  The 
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FIG. I I I . 6. E ffects o f ammonium ch loride  on BCV y ie ld  by HRT-18 c e lls  
(A) synchronously infected w ith v irus  and (B) in fected with 
v irus  at 37°C. Dashed lines  represent v irus  y ie ld  when 10 
mM ammonium ch lo ride  was added at 1 h post in fe c tio n .
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FIG. I I I . 7. E ffec t o f chloroquine on BCV y ie ld  by c e lls  (A) in fected 
synchronously and (B) infected at 37°C. Dashed lines 
represents v irus  leve l when 120 uM chloroquine was added at 
1 h post in fe c tio n .
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10 mM ammonium ch lo ride . A s im ila r unresponsiveness to ammonium 
ch loride  treatment occurred during in fec tio n  at 37°C. The pretreatment 
w ith 10 mM ammonium ch loride caused only a 37% decrease in BCV from 
leve ls  produced when the agent was added a fte r  a 1 h delay (FIG.
I I I .6 B ) .  However, 80 to  200 uM chloroquine strongly inh ib ite d  
synchronous in fe c tio n  by BCV (FIG. I I I .7 A ) .  Cells pretreated w ith  th is  
agent and infected at 37°C also produced less v irus  in  response to 
increasing concentrations o f the in h ib ito r  (FIG. I I I .7 B ) .  The optimal 
in h ib ito ry  concentration o f chloroquine, in  terms o f the d ifference 
between v irus leve ls re su lting  from fu l l  and delayed treatment 
experiments was 120 urn. Concentrations o f the drug higher than 200 uM, 
when treatment was delayed fo r  1 h, diminished to ta l v irus  y ie ld  to  
nearly the leve ls obtained by pretreatment. The in h ib ito ry  e ffe c t o f 
120 uM chloroquine on the early stages o f BCV re p lica tio n  was therefore 
examined more c lose ly  in subsequent experiments.
I I I .C .4 .  Chloroquine in h ib it io n  o f v ira l antigen production in  
in fected c e lls .  Immunofluorescence studies revealed tha t chloroquine 
treatments also affected the number o f BCV-infected c e lls  in HRT-18 
monolayers (Table I I I . 2). Treatments o f synchronously infected 
cu ltures g rea tly  decreased the number o f fluorescent, antigen 
producing c e lls  at 12 to 36 h post in fe c tio n . Replication o f BCV 
occurred in 10% to 17% o f the c e ll population in untreated cu ltu res. 
Only 1% or less o f the c e ll population produced BCV antigens when 
exposed to chloroquine at the time o f in fe c tio n . The numbers o f 
fluorescent c e lls  in the monolayers reached nearly normal leve ls  when
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th is  treatment was delayed fo r  1 h even though c e ll vacuolization was 
pronounced.
Table I I I . 2. Chloroquine e ffe c t on antigen production
Drug
Exposure
%Fluorescing c e lls 3
12 h 18 h 36 h
None 10 17 10
Full 1 0 1
Delayed 9 5 11
aFluorescent c e ll population expressed as percent o f 
to ta l at indicated times post in fe c tio n .
1I1.C.5. Time dependence o f s e n s it iv ity  to  chloroquine 
in h ib it io n . The time po in t fo r  the early  re p lic a tiv e  step susceptible 
to  chloroquine in h ib it io n  was more precise ly determined (FIG. I I I . 8 ). 
Synchronously infected monolayers were treated w ith chloroquine at 
various times post in fe c tio n . Virus y ie lds  remained at low leve ls in 
cu ltures exposed to the drug at 5 min or less. Exposure to 
chloroquine at 10 min post in fe c tio n  reduced v irus  y ie ld  by more than 
75%. In h ib it io n  at 50% o f maximum occurred w ith a treatment delay o f 
approximately 15 min. These resu lts  ind ica te  tha t 5 to  10 min were 
required fo r  BCV re p lica tio n  to proceed beyond the chloroquine 
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FIG. I I I . 10. E ffec t o f chloroquine on in fe c t iv i ty  o f BCV p a rtic le s .
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I I I . e . 6. Independence o f chloroquine in h ib it io n  to  pH 
treatments. In an attempt to overcome the chloroquine imposed block in 
BCV entry, we tr ie d  to  stim ulate fusion between the plasma membrane and 
envelopes o f in fe c tin g  v ir io n s . Monolayers w ith v irus  adsorbed at 4°C 
were exposed to chloroquine and b r ie f ly  treated w ith warm buffers at 
various pH leve ls  to  simulate conditions in in tra c e llu la r  vacuoles. We 
found th a t chloroquine was an e ffe c tiv e  in h ib ito r  o f BCV in fe c tio n  
despite bu ffe r treatments in the range o f 4.4 to  8.4 (FIG. I I I . 9).
D irect e ffe c ts  o f chloroquine on HRT-18 c e ll v ia b i l i t y  or on BCV 
in fe c t iv i ty  were apparently not responsible fo r  the in h ib it io n . Each 
o f the four lysosomotropic agents caused cyto log ica l changes in HRT-18 
c e lls  characterized by the development o f large cytoplasmic vacuoles. 
With 120 uM chloroquine treatment, vacuolization began w ith in  three 
hours a fte r  exposure and reached maximum development a fte r  12 hours.
A fte r 20 hours o f treatment, however, c e ll v ia b i l i t y  remained as high
as 90%. Furthermore, chloroquine treatment o f in fe c tive  BCV p a rtic le s  
had l i t t l e  e ffe c t on the ra te  o f in a c tiva tio n  during the f i r s t  twelve
hours o f exposure (FIG. I I I . 10).
I I I .D .  DISCUSSION.
Many aspects o f the in i t ia l  stages in v irus  in fe c tio n  are 
disputed because current knowledge o f th is  subject is  in a p r im itive  
stage (32). Recent investiga tions have re-examined the ro le  o f 
endocytosis in  in fections by several animal viruses. Morphologic 
analyses have generally indicated tha t coronaviral entry is
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accomplished by endocytosis (18, 25, 26, 107); yet other investiga tions 
have suggested tha t coronaviruses enter the c e ll by d ire c t fusion w ith 
the plasma membrane (34). One o f the objectives o f our study was to 
employ immunolocalization to  investiga te  the entry pathway fo r  BCV.
Electron microscopic analysis confirmed tha t BCV p a rtic le s  were 
endocytosed by HRT-18 c e lls . Shortly a fte r  warming, the v irus 
p a rtic le s  were seen in coated p its  and in small endocytic vesicles w ith 
smooth membranes. The p a rtic le s  accumulated la te r  in  structures tha t 
appeared to  be secondary lysosomes. Fusion o f the v ira l envelope w ith 
the plasma membrane was observed but we were never able to fin d  clear 
morphologic evidence o f membrane fusion events along the in tra c e llu la r  
membranes. This evidence indicates tha t BCV may e ffe c t in fectious 
entry by d ire c t fusion at the ce ll surface.
Experiments w ith lysosomotropic weak bases were conducted to 
id e n tify  a requirement fo r  an ac id ic  compartment during BCV entry.
Such a requirement would support the endocytic pathway fo r  in fectious 
entry o f th is  v iru s . Our resu lts  ind icate  tha t an ac id ic  compartment 
is  not required fo r  BCV entry in to  HRT-18 ce lls  and thus fa i l  to 
support the endocytic pathway as an a lte rn a tive  route fo r  in fe c tio n . 
Ammonium chloride and methylamine were not in h ib ito ry  fo r  events in  the 
f i r s t  hour o f BCV re p lic a tio n . Although amantadine treatment from the 
time o f in fec tio n  reduced v irus y ie ld , the agent was also to x ic  when 
added a fte r  a 60 min delay.
Chloroquine in te rfe red  w ith an early  stage o f BCV re p lica tio n  as 
determined by the y ie ld  o f in fec tious  v irus and by the number of 
BCV-infected c e lls . This e ffe c t apparently did not involve in h ib it io n
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o f v ira l envelope fusion w ith ce ll membranes. The k in e tics  o f time 
dependence fo r  chloroquine in h ib it io n  suggests tha t the sens itive  step 
in BCV re p lica tio n  occurs beyond 5 min post in fe c tio n  (FIG. I I I .7 A ) .  
Addition o f chloroquine as la te  as 10 min in h ib its  re p lica tio n  
su b s ta n tia lly  (75%). In contrast, Semliki fo res t v iru s , which enters 
the ce ll by the endocytic pathway, procedes beyond the chloroquine 
sensitive  phase w ith in  4 min a fte r in fec tion  and la te r  treatments w ith 
the base are re la tiv e ly  in e ffe c tiv e  (47).
B rie f treatment o f Semliki fo rest virus-adsorbed c e ll cu ltures 
w ith  low pH media circumvented the chloroquine block apparently by 
allowing v irus fusion at the plasma membrane (47, 158). The 
chloroquine blocked step in BCV in fe c tio n  was e sse n tia lly  unaffected by 
pH treatments in the range o f 4.4 to 8.4. The fa ilu re  o f such 
treatments to re lieve  the chloroquine block in  BCV re p lica tio n  may have 
several explanations. Plasma membrane fusion w ith BCV may not be 
triggered by low pH treatments. Other studies in our laboratory 
ind ica te  tha t th is  is  the case fo r  BCV-infected bovine fe ta l spleen 
c e lls  were pH 8 is  optimal fo r  ce ll fusion induced by th is  v irus  (H. R. 
Payne and J. Storz, manuscript in preparation). Cell fusion induced by 
a murine coronavirus also occurs optim ally at a s l ig h t ly  basic pH 
(138). A second possible reason fo r a continued chloroquine block 
despite low pH treatment is  tha t in h ib it io n  may involve events in 
re p lica tio n  subsequent to fusion. Studies o f Sindbis v irus  in fe c tio n  
have concluded tha t chloroquine in h ib its  only postfusion events in the 
re p lica tio n  o f th is  v irus (13). In those experiments, the a n t iv ira l
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a c t iv ity  o f the in h ib ito r  was found to re su lt from an e ffe c t on v ira l 
RNA synthesis ra ther than a block in Sindbis v irus  entry in to  the c e ll .
Our data ind ica te  th a t BCV in fe c tio n  does not involve the 
endocytic route. Endocytosis o f th is  v irus appears to  represent an 
abortive in fe c tio n  w ith subsequent v irus  degradation in  lysosomes. The 
v ir io n s  th a t were endocytosed were not observed to fuse w ith  the 
vesic le  membranes. Instead, the p a rtic le s  accumulated in a somewhat 
degraded form in lysosome-1ike structu res. Furthermore, a low pH 
compartment is  apparently unnecessary fo r  BCV in fe c tio n  and 
virus-induced membrane fusion seems to be an event independent o f low 
pH treatments. These features suggest tha t BCV in fe c ts  c e lls  by d ire c t 
fusion w ith the plasma membrane. Doughri, e t a l . (34) observed 
in te rac tions  o f BCV s tra in  LY-138 w ith the plasmalemma o f in fected 
in te s tin a l e p ith e lia l c e lls  and asserted tha t v irus  uptake had occurred 
by d ire c t fusion w ith the plasma membrane. Our studies provide 
evidence to  support tha t conclusion.
CHAPTER iV; EXPRESSION OF BOVINE CORONAVIRUS ANTIGENS AT
THE PLASMA MEMBRANE OF INFECTED CELL CULTURES
IV.A. INTRODUCTION.
Bovine coronavirus (BCV) is  associated w ith many cases o f en te ric  
disease o f v ira l e tio logy  in newborn calves (54). The large, enveloped 
v ir io n s  contain a p o s itive  sense RNA genome and are surrounded by a 
fr in g e  o f ch a ra c te ris tic  club-shaped peplomers. Five to  e ight 
immunogenic polypeptides, one o f which is  in te rn a l, have been reported 
fo r  BCV v ir io n s  (62, 63, 78, 130). The major envelope-associated 
polypeptides o f coronaviruses are glycosylated and carry the s truc tu ra l 
s ite s  responsible fo r  hemagglutination and v iru s -c e ll in te rac tions  (20, 
63, 136).
Coronaviruses usually e xh ib it lim ite d  c e ll and species tropisms. 
For th is  reason, apparently, the in i t ia l  is o la tio n  o f f ie ld  s tra ins  o f 
BCV is  most successful in the human adenocarcinoma c e ll lin e  HRT-18. 
Monolayers o f these polarized ep ithe liod  c e lls  s tru c tu ra lly  resemble 
enterocytes - -  the type o f c e lls  targeted by BCV in natural in fec tions  
(33). Cultures o f bovine fe ta l spleen (BFS) c e lls  can also support the 
m u ltip lic a tio n  o f the cell-adapted s tra in  o f BCV (96). Unlike HRT-18 
c e lls , BFS c e lls  are h igh ly  susceptible to  BCV-induced c e ll fusion i f  
tryp s in  is  added to the medium o f the in fected cu ltu re  (135). This 
phenomenon, known as fusion from w ith in , suggests tha t the v ira l fusion
fa c to r is  present at the surface o f in fected c e lls  (160). V ira l
prote ins in  the host plasma membrane are not necessary fo r  BCV
maturation, however, because coronaviral p a rtic le s  are enveloped only
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by budding in to  in tra c e llu la r  compartments (136). V ira l components at 
the c e ll surface may contribu te  to  in tra c e llu la r  spread o f the 
in fe c tio n  and may also serve as targets fo r  immune attack.
In th is  report, we describe the use o f immunoelectron microscopy 
to characterize the appearance o f BCV proteins in the plasma membrane 
o f the host c e l l .
IV.B. MATERIALS AND METHODS.
IV .B .l. Cells and v iru s . Monolayers o f the human recta l tumor 
c e ll l in e  HRT-18 (145) were maintained in Dulbecco modified Eagle 
medium (DMEM) buffered w ith  44 mM NaHC03 and supplemented w ith  5% fe ta l 
c a lf  serum. The D2 s tra in  o f BFS c e lls  was maintained in minimal 
essential medium (MEM) buffered w ith  25 mM HEPES and supplemented w ith 
10% fe ta l c a lf  serum. Stock preparations o f the Mebus s tra in  L9 o f BCV 
(121, 131) were propagated in HRT-18 c e lls . Virus stocks were 
generated from c e lls  in fected at a m u lt ip l ic i ty  o f approximately 0.01 
PFU per c e l l ,  incubated fo r  4-5 days at 37°C in serum-free DMEM and 
harvested by freeze-thawing. V ira l t i te r s  obtained in these 
preparations ranged from 106 to  107 PFU per ml.
IV .B .2. In fec tion  o f c e ll cu ltu res . Monolayers fo r  immunogold 
labe ling  experiments were grown in 20 cm2 so lven t-res is tan t cu ltu re  
dishes and monolayers fo r  immunofluorescence studies were cu ltiva te d  in 
m ultiw e ll chamber s lides (Miles S c ie n t if ic ) .  HRT-18 c e lls  were washed 
w ith DMEM, and infected w ith BCV fo r  60 min at 37°C at a m u lt ip l ic ity  
o f approximately 1.5 PFU per c e l l .  The cu ltu res were fed w ith fresh
DMEM and incubated at 37°C in a 5% C02 atmosphere. In a s im ila r 
manner, monolayers o f BFS c e lls  were washed w ith MEM and in fected w ith 
BCV at a m u lt ip l ic ity  o f 20 PFU per c e l l .  Infected BFS cu ltures were 
maintained in MEM w ith and w ithout the addition o f 0.2 ug/ml o f tryps in  
which contained to ly ls u lfo n y l phenyalanyl chloromethyl ketone to 
in h ib it  chymotrypsin a c t iv ity  (Sigma Chemical Company). At various 
times post in fe c tio n , cu ltures were removed from the incubator and 
fixed  at 4°C fo r immunolabeling.
IV .B .3. In d ire c t immunofluorescence. Infected monolayers were 
fixed  fo r  10 min in 4% formaldehyde in 0.01 M NaP04, 0.14 M NaCl, pH 
7.3 (PBS), w ith 0.005% CaCl2 and 0.11 M sucrose, permeabilized fo r  5 
min w ith acetone at -20°C, incubated w ith rabb it anti-BCV antibody, and 
reacted w ith goat a n ti-ra b b it antibody conjugated to  fluoresce in  
isothiocyanate. The preparations were viewed w ith a Le itz  fluorescent 
microscope using epifluorescence.
IV .B .4. Immunogold lo c a liz a tio n . Cell monolayers were fixed  fo r 
30 min at 4°C in 1% glutaraldehyde in PBS, pH 7.3, and washed overnight 
in  PBS followed by a 10 min treatment w ith ImM g lycy lg lyc in e . The 
fixed  monolayers were labeled at 4°C by an incubation in rabb it 
anti-BCV IgG followed by an incubation w ith goat a n ti- ra b b it :c o llo id a l 
gold complex. Infected control monolayers were incubated w ith normal 
rabb it IgG instead o f anti-BCV antibody.
IV .B .5. Processing fo r e lectron microscopy. The gold labeled 
monolayers were fixed  again in 1% glutaraldehyde in PBS fo r  1 h at 
25°C, incubated fo r  1 h in  a so lu tion o f 1% osmium te trox ide  and 1% 
potassium ferrocyanide in PBS, washed in  0.2 M sodium acetate bu ffe r, 
pH 3.5, and stained en bloc fo r  1 h w ith 0.2% uranyl acetate in acetate
b u ffe r. A fte r washing in d is t i l le d  water, the ce lls  were dehydrated in
an ascending alcohol gradient, embedded in  s itu  in  Spurr's epoxy resin 
(129), and polymerized at 60°C. The embedded monolayers were peeled 
from the p la s tic  substrate, reembedded, and oriented so tha t th in  
sections were cut perpendicular to the monolayer plane. The th in  
sections were stained w ith uranyl magnesium acetate followed by lead 
c it ra te  and viewed w ith a Zeiss EM-10 electron microscope at 80 kV.
IV .B .6. Immunoreagents. Rabbit antiserum to  BCV tha t had been 
p u rifie d  from infected bovine fe ta l kidney c e lls  was prepared by
previous investiga to rs in our lab. The antibody leve l was t ite re d  by a
plaque neu tra liza tio n  te s t.  The IgG frac tions  o f the anti serum and o f 
normal rabb it serum were obtained by prote in A-sepharose column 
chromatography. Goat a n ti-ra b b it antibody (IgG) complexed to  5-nm 
c o llo id a l gold p a rtic le s  (Janssen L ife  Sciences Products, Beerse, 
Belgium) was used. The immunoreagents were d ilu te d  in PBS containing 
0.5% goat serum.
IV.C. RESULTS.
IV .C .l. Expression o f BCV antigens in  HRT-18 c e lls .  We selected 
the HRT-18 lin e  as host c e lls  fo r study because these c e lls  share
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d is t in c t iv e  morphological features w ith absorptive c e lls  o f the 
in te s tin a l mucosa. V iru s -spec ific  fluorescence was observed in 
approximately 10% o f the c e ll population at 12, 24, and 36 h a fte r  
in fe c tio n  (FIG. IV .1). The percentage o f fluorescent c e lls  in the 
cu ltu re  increased l i t t l e  a t the la te r  times. We examined th in  
sections o f immunolabeled HRT-18 ce lls  to detect BCV antigens at the 
ce ll surface. Cells fixed  p r io r  to  9 h were not marked but the 
c o llo id a l gold p a rtic le s  were observed at widely scattered locations on 
the apical surfaces o f c e lls  fixed  at 12 h (FIG. IV .2). The surfaces 
o f infected HRT-18 ce lls  were abundantly labeled by 24 h (FIG. IV .3). 
The gold-labeled BCV antigens were located on both m ic ro v il l i  and on 
planar portions o f the apical plasma membrane. The gold p a rtic le s  were 
separated s p a tia lly  and c lus te ring  o f BCV antigens in the membrane 
plane was not apparent. T yp ica lly , these densely labeled c e lls  were 
surrounded by ce lls  tha t were not marked by gold p a rtic le s .
Control preparations included ( i )  uninfected HRT-18 c e lls  tha t 
were incubated w ith anti-BCV antibody and ( i i )  infected c e lls  tha t were 
incubated w ith the IgG fra c tio n  o f normal rabb it serum. These c e lls  
were not labeled by the gold probe because the antibody bound only to  
v iru s -s p e c ific  antigens. A d d itio n a lly , in re la ted studies, we observed 
tha t the plasma membrane is  not labeled on uninfected HRT-18 c e lls  
adsorbed at 4°C w ith BCV and incubated w ith these immunoreagents 
(Manuscript in preparation. H.R. Payne, W.G. Henk, and J. S torz). 
Therefore, binding o f subviral components to  c e llu la r  receptors did not 
contribu te  to the association o f gold p a rtic le s  w ith the plasma 
membrane. Our attempts to use post-embedment techniques to  id e n tify
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FIG. IV .1. Immunofluorescence o f BCV antigens in  in fected HRT-18 c e lls  
at 24 h post in fe c tio n . Bar = 50 urn.
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FIG. IV .2. Immunogold labeled HRT-18 c e lls  at 12 h post in fe c tio n  w ith 
BCV. Locations o f v ira l antigens are marked by gold 
p a rtic le s  (arrowheads). Bar = 200 nm.
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FIG. IV .3. Immunogold labeled infected HRT-18 c e lls , 24 h post 
in fe c tio n . V, coronavirion. Bars = 200 nm.
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v ira l antigens at basolateral aspects o f the c e ll membrane were 
unsuccessful.
IV .C .2. Expression o f BCV antigens in  BFS c e lls .  Fusion o f BFS 
c e lls  was induced by BCV re p lica tio n  when cultures were incubated in 
medium w ith tryp s in  (FIG. IV .4). Cell fusion was not observed in the 
absence o f tryp s in . The fusion process may contribu te  to  in te rc e llu la r  
spread o f the in fe c tio n  by the recruitment o f uninfected c e lls  in to  
enlarging polykaryons. We used immunofluorescence and immunogold 
electron microscopy to co rre la te  observations o f the onset o f ce ll 
fusion w ith the development o f v ira l antigens. Faint fluorescence was 
f i r s t  recognized in  the cu ltu re  at 9 h post in fe c tio n . Approximately 
33% o f the ce ll population fluoresced at 15 h (FIG. IV.5A). Cell 
fusion was in i t i a l l y  evident at 18 h in cu ltures incubated w ith 
tryp s in . These cultures contained large polykaryons w ith cytoplasmic 
fluorescence at 24 h (FIG. IV .5). Only mono- and bi-nucleated c e lls , 
o f which 25% were fluorescent, were observed at 24 h in the absence o f 
tryp s in . Uninfected c e lls  predominated in these cu ltures while fewer 
than 10% o f the remaining single c e lls  in tryp s in -trea te d  cu ltures were 
nonfluorescent at 24 h.
Electron microscopic observations revealed no evidence o f ce ll 
fusion in BFS monolayers fixed  a fte r  15 h o f in fe c tio n  in  the presence 
o f tryps in  (FIG. IV.6A). The immunogold technique labeled m u ltip le  
s ites  o f BCV antigens in  the plasma membrane at th is  time, however 
(FIG. IV.6B). At la te r  times, tryp s in  treatment had no apparent e ffe c t 
on the abundance o f labeled antigens at the c e ll surface (FIG. IV .7).
Polykaryocytosis in v irus infected BFS c e lls . (A) Cells 
incubated w ithout tryps in  did not fuse. (B) Polykaryons 
formed a fte r  24 h incubation w ith tryp s in . Giemsa stained 
preparations. Bars = 50 urn.
59
FIG. IV .5. Immunofluorescence o f v irus infected BFS c e lls  at (A) 15 h 
post in fe c tio n  and (B,C) at 24 h post in fe c tio n . Cultures 
in (A) and (C) were infected in the presence o f tryp s in . 
Bars = 50 um.
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FIG. IV .6. Immunogold labeled BFS c e lls  at 15 h post in fe c tio n  in  the 
presence o f try p s in . Bars = 1.0 urn in  (A) and 50 nm in  (B) 
and (C).
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FIG. IV .7. Immunogold labeled BFS c e lls  at 24 h post in fe c tio n  in  the 
(A) presence and (B) absence o f tryp s in . Bars = 200 nm.
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The number o f gold binding s ites  on polykaryons at 24 h was 
approximately equal to  tha t o f c e lls  not treated w ith tryp s in .
IV.D. DISCUSSION.
We used immunolocalization techniques to probe morphological 
cha rac te ris tics  o f BCV in fe c tio n  in an ep ithe liod  c e ll lin e  (HRT-18) 
and in bovine f ib ro b la s t ic  ce lls  (BFS) which are h igh ly susceptible to 
BCV-induced c e ll fusion. The envelopment o f BCV occurs on 
in tra c e llu la r  membranes. Despite th is  in tra c e llu la r  mode o f 
maturation, we demonstrated tha t BCV antigens are expressed at the 
surfaces o f in fected c e lls  o f both types. These immunogold-labeled 
surface antigens were found in areas free o f attached v ir io n s . The 
immunogold technique labeled BCV antigens but did not label c e llu la r  
antigens or ce ll-su rface  adsorbed subviral components in control 
preparations. Consequently, the s ites  at the c e ll surface labeled by 
gold represent de novo expression o f v iru s -s p e c ific  proteins in the 
plasma membrane.
Although HRT-18 monolayers were infected w ith BCV at a 
m u lt ip l ic ity  o f 1.5 PFU per c e l l ,  only a m inority  o f these c e lls  
developed cytoplasmic fluorescence w ith in  36 h. The large population 
o f non-fluorescent c e lls  probably were less susceptible to  v irus 
in fe c tio n  or were nonpermissive fo r  synthesis o f v ira l prote ins. The 
frequent presence o f immunogold-labeled HRT-18 c e lls  in th in  sectioned 
preparations adjacent to uninfected c e lls , free o f the gold marker, 
support th is  in te rp re ta tio n . V ira l antigens could f i r s t  be
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demonstrated in the apical plasma membrane by 12 h, but the antigens 
increased to higher density by 24 h.
Polykaryocytosis was evident by 18 h in  in fected BFS c e lls  
incubated in medium w ith tryp s in . Following the onset o f c e ll fusion 
in these cu ltu res, the number o f non-fluorescing BFS c e lls  was reduced. 
Para lle l cu ltures incubated w ithout tryps in  maintained a stable number 
o f non-fluorescing c e lls . The decrease evidently  resulted from the 
recruitment o f uninfected c e lls  in to  enlarging polykaryons. This 
process may re la te  to  a ce ll-associa ted spread o f the v irus  in fe c tio n . 
The decreased number o f non-fluorescent BFS c e lls  also might re su lt 
from an increased e ffic ie n cy  in the in fe c tion  process re su lting  from 
tryps in  a c tiva tion  o f the fusion fa c to r (130).
Infected BFS c e lls  produced cytoplasmic BCV antigens w ith in  9 h, 
and expressed v ira l antigens in the plasma membrane at 15 h in the 
presence o f tryp s in . Consequently, v ira l antigen appeared at the 
plasma membrane several hours p r io r  to the onset o f c e ll fusion which 
was f i r s t  observed at 18 h. BFS polykaryons fa ile d  to accumulate more 
v ira l antigens in the plasma membrane a fte r the onset o f c e ll fusion. 
This surpris ing  re su lt contrasted with the progressive accumulation o f 
v ira l antigens in infected HRT-18. The re su lt could be caused by 
several possible d ifferences between the infected ce ll types including 
( i )  the k ine tics  o f prote in  transport to  the plasma membrane and ( i i )  
the process o f membrane recyc ling . When tryp s in  was omitted from the 
medium o f in fected BFS c e lls , antigens were expressed at the plasma 
membrane although c e ll fusion never occurred. This observation 
indicates tha t the action o f tryps in  in polykaryon formation involves
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e ffe c ts  other than an increase in  the number o f v ira l antigens at the 
c e ll surface.
Coronavirus p a rtic le s  may be released by in ta c t ce lls  (51, 136) 
or by cy to lys is  o f the infected c e lls  (33, 34, 136). We observed v irus 
p a r t ic le - f i l le d  vesicles continuous w ith the plasma membrane as early 
as 15 h a fte r in fe c tio n  in BFS c e lls  (FIG. IV.6C). This event appears 
to  represent exocytosis o f newly formed coronavirus p a rtic le s . Fusion 
o f such vesicles w ith the plasma membrane would leave excess v ira l 
proteins at the c e ll surface and account fo r  the appearance of 
antigens.
Our resu lts  are in agreement w ith reports o f v ira l prote ins at 
the surface o f c e lls  infected w ith mouse coronaviruses. C o llins  et a l . 
(20) used immunoferritin electron microscopy to  demonstrate tha t the 
170,000 molecular weight (GP-1) prote in  o f MHV-4 is  present at the 
surface o f infected L-241 c e lls  at 6 h post in fe c tio n . Other evidence 
fo r  coronavirus-specific  proteins at the c e ll surface has re lie d  on 
in h ib it io n  o f virus-induced ce ll fusion by antibodies sp e c ific  fo r  
envelope proteins (52, 136, 138) and on fusion foc i experiments (99, 
146). Our immunogold procedure reveals the precise s ites  o f 
coronaviral antigens in the plasma membrane and extends the e a r lie r  
observations to  include the bovine coronavirus.
The expression o f BCV antigens in the plasma membrane has 
important im plications fo r  host-v irus in te rac tions  aside from 
polykaryon formation. For example, appearance o f v iru s -sp e c ific  
surface components during eclipse may render the infected ce ll 
susceptible to  sp ec ific  antibody-dependent or cell-mediated host
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defense mechanisms. The in fected c e ll could p o te n tia lly  be destroyed 
p r io r  to the release o f new v iru s .
CHAPTER V: ANALYSIS OF MEMBRANE FUSION INDUCED
BY BOVINE CORONAVIRUS INFECTION 
V.A. INTRODUCTION.
In fection  o f animal c e lls  by enveloped viruses involves fusion 
between the v ira l envelope and a c e ll membrane. The fusogenic 
po ten tia l o f viruses has been studied in  v it ro  w ith systems using 
erythrocytes, cultured c e lls , and liposomes as ta rge t membranes (55,
57, 152, 159, 160). Membrane fusion is  induced by paramyxoviruses at 
neutral pH thus these viruses may enter the host c e ll at physiological 
pH by fusing w ith the plasma membrane at the c e ll surface (reviewed in 
19, 32). In contrast, the c e ll fusion a c t iv it ie s  o f Semliki fo res t 
v iru s , influenza v iru s , and vesicu lar s tom a titis  v irus  are s t r ic t ly  
dependent on ac id ic  pH leve ls  (37, 43, 158, 159). Low pH is  used 
experimentally to  simulate conditions ex is ting  w ith in  the ac id ic  
in tra c e llu la r  vesicles where penetration by these viruses is  thought to 
n a tu ra lly  occur.
Cell fusion and polykaryon formation in cu ltures in fected w ith 
bovine coronavirus (BCV) occur la te  in the v irus  re p lic a tiv e  cycle.
In many types o f host c e lls , polykaryocytosis is  dependent on the 
presence o f tryps in  during the course o f BCV re p lica tio n  (135). The 
membrane events o f virus-induced c e ll fusion and v iru s -c e ll fusion 
during entry appear to be based on the same p rin c ip le  (68) but the mode 
o f BCV penetration o f the host c e ll has not been reported. We studied 
the tryps in  s u s c e p tib ility  o f BCV-infected c e lls  and found tha t fusion 
is  optimal at pH 7.5 to  8.0. Our observation tha t a lka lin e  conditions
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support BCV-induced polykaryocytosis suggests tha t th is  v irus  may 
penetrate c e lls  by d ire c t fusion w ith the plasma membrane.
V.B. MATERIALS AND METHODS.
V .B .l. Virus and c e lls .  Stock preparations o f the Mebus s tra in  
L9 o f BCV (121, 131) were propagated in  the human recta l tumor c e ll 
lin e  HRT-18 (145). Virus stocks were generated from c e lls  in fected at 
a m u lt ip l ic i ty  o f approximately 0.01 PFU per c e l l ,  incubated fo r  4-5 
days at 37°C in Dulbecco modified Eagle medium (DMEM) buffered w ith 44 
mM NaHC03 and harvested by freeze-thawing. V ira l t i t e r s  in these 
preparations ranged from 106 to 107 PFU per ml. The D2 s tra in  o f BFS 
c e lls  was maintained in  minimal essential medium (MEM) buffered w ith 25 
mM HEPES and supplemented w ith 10% fe ta l c a lf  serum.
V.B.2. E ffects o f tryp s in  and tryp s in  in h ib ito r  on BCV 
re p lic a tio n . Monolayers grown in  25 cm2 flasks were inoculated w ith 
BCV at a m u lt ip l ic ity  o f 2 PFU per c e l l ,  incubated at 37°C fo r  60 min 
and washed w ith MEM. The cultures were incubated in  MEM containing 
tryp s in  (0.4 ug per ml; Sigma Chemical Company) treated w ith 
to ly ls u lfo n y l phenyalanyl chloromethyl ketone, an in h ib ito r  o f 
chymotrypsin a c t iv ity .  T rypsin-treated and untreated cu ltu res were 
also exposed to soybean tryps in  in h ib ito r  (0.4 ug per ml; Sigma 
Chemical Company) during the period o f tryp s in  treatment. A fte r 24 h, 
the cu ltures were harvested by two freeze-thaw cycles and the material 
was disrupted by sound (Branson Sonic Power Company) fo r  30 sec on ice
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to  release the v iru s . Virus y ie lds  were determined by plaque assays 
and hemagglutination assays.
V.B.3. Virus-induced polykaryon formation. Monolayers o f BFS 
c e lls  were grown in 24-well plates washed w ith MEM and adsorbed fo r  1 h 
at 37°C w ith BCV at a m u lt ip l ic ity  o f 20 PFU per c e l l .  The cu ltures 
were covered w ith MEM w ith and without the add ition o f 0.4 ug o f 
tryp s in  per ml and incubated at 37°C. Exposure to  tryp s in  a c t iv ity  
p r io r  to  harvest was terminated by rin s in g  the monolayer once w ith MEM 
then adding MEM containing 0.4 ug o f soybean tryps in  in h ib ito r  per ml. 
The cu ltures were incubated fo r  26 h o f in fe c tio n , fixed  fo r  10 min in 
Bouin's f ix a t iv e  and stained w ith Giemsa. The c e lls  were examined 
m icroscopically w ith a 25X ob jective and the extent o f c e ll fusion was 
scored by counting the number o f polykaryons w ith 4 or more nuclei in  5 
randomly selected f ie ld s .
V.B.4. E ffec t o f pH level on virus-induced fus ion . Prelim inary 
experiments were conducted to  id e n tify  the time period in which 
BCV-infected BFS c e lls  are susceptible to  the presence o f tryp s in .
Each in fected monolayer was exposed to tryps in  fo r  a 1, 2, or 4 h 
in te rva l during the period o f v irus re p lic a tio n . A fte r 26 h, the 
monolayers were fixe d , stained, and scored fo r  polykaryon formation.
We then analyzed the e ffec ts  o f the pH level on polykaryon 
formation. The monolayers were infected as described above and 
incubated in MEM buffered w ith 10 mM HEPES and 10 mM MES at pH 7.0,
7.5, and 8.0 fo r  19 h at 37°C w ithout tryp s in . The c e lls  then were
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treated fo r  2 h at 37°C w ith 1.0 ug o f tryp s in  per ml o f MEM at various 
pH leve ls . The tryps in  treatment was terminated and the monolayers 
were incubated fo r  an add itional 5 h in tryp s in -fre e  medium at pH 8.0 
before f ix a tio n  and s ta in ing .
V.B.5. Antibody suppression o f c e ll fusion. The IgG fra c tion s  
o f the ra bb it anti-BCV serum and o f normal rabb it serum were obtained 
by prote in A-sepharose column chromatography. The a b i l i t y  o f anti-BCV 
IgG to  a ffe c t polykaryon formation at 37°C was tested by two 
procedures: ( i )  Infected c e ll monolayers were incubated fo r  6 h in 
tryp s in -fre e  MEM then exposed to MEM tha t contained antibody fresh ly  
d ilu te d  w ith tryp s in . These monolayers were fixed  and stained a fte r  18 
h o f in fe c tio n , ( i i )  Monolayers were infected fo r  9 h then treated 
w ith antibody fo r  1 h in the absence o f tryp s in . The ce lls  were 
covered w ith medium containing tryps in  a fte r  the antibody treatment, 
incubated fo r  an additional 8 h, and then fixed .
V.C. RESULTS.
V .C .l. E ffects on tryps in  and tryp s in  in h ib ito r  on BCV 
re p lic a tio n . The presence o f tryps in  at some time during v irus  
re p lica tio n  in BFS c e lls  was an absolute requirement fo r  the 
development o f polykaryons under a ll conditions tested in th is  study. 
Cell fusion fa ile d  to occur in infected cu ltures w ithout tryp s in  or 
when soybean tryps in  in h ib ito r  was present during treatment. BCV 
re p lica tio n  apparently proceeded unabated in the absence o f tryp s in .
The addition o f tryp s in  to  infected cu ltures at 3 h increased the y ie ld
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o f in fec tious  v irus by only 38% but the hemagglutination t i t e r  rose by 
400%. Addition o f tryp s in  in h ib ito r  to infected cu ltures caused a 
small (39%) decrease in the y ie ld  o f in fectious v irus  but the 
hemagglutination t i t e r  was unaffected. These re su lts  suggest tha t 
treatment w ith e ith e r tryp s in  or tryp s in  in h ib ito r  had no substantial 
e ffe c t on the y ie ld  o f in fec tious  v irus during a s ing le cycle o f v irus  
re p lica tio n .
V.C.2. Replication period susceptible to  try p s in . Experiments 
conducted to  id e n tify  the period o f in fe c tio n  susceptible to  tryps in  
ac tiva tion  o f fusion revealed tha t the onset o f c e l l- to -c e ll  fusion 
occurred at about 18 h post in fe c tio n  w ith continuous tryps in  
treatment. This treatment resulted in large m ulti nucleated c e lls  by 26 
h (FIG.V.1). We found tha t a s ing le tryps in  treatment fo r  an in te rva l 
as b r ie f  as 1 to  2 h could re su lt in the formation o f polykaryons a fte r 
26 h. These polykaryons generally were smaller and contained fewer 
nuclei per ce ll than the fusion products o f continuous tryps in  
treatment.
In te rva ls  o f tryps in  treatment tha t ended p r io r  to  14 h post 
in fe c tio n  produced less than 6% polykaryocytosis (FIG. V.2). The 
greatest numbers o f polykaryons (74 to  124 per f ie ld )  developed in 
monolayers treated fo r  a 2 or 4 h in te rva l during the period between 18 
and 22 h post in fe c tio n . This observation was used in  subsequent 
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FIG. V . l.  Polykaryon formation in BFS cultures infected 26 h w ith
BCV. (A) Large polykaryons (arrowhead) develop in cu ltures 
treated continuously w ith tryp s in . (B) Smaller polykaryons 
(arrowheads) develop when the tryps in  treatment is  lim ite d  
to a 2 h period (20 to  22 h). (C) No polykaryons develop 
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FIG. V.2. Trypsin a c tiva tio n  o f BCV-induced polykaryocytosis.
Infected monolayers were exposed to  tryp s in  fo r  a s ing le  2 
or 4 h in te rva l as ind ica ted. Maximum polykaryocytosis 
occurred in cu ltu res exposed to  tryp s in  during the period 
from 18 to  22 h post in fe c tio n .
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V.C.3. Required pH level fo r fusion o f in fected c e lls .  We then 
determined the pH level optimal fo r  promotion o f polykaryon formation. 
Infected cu ltures incubated fo r  19 h in the absence o f tryps in  were 
exposed fo r  2 h to  tryps in-con ta in ing  media a t various pH leve ls . 
Trypsin treatment at pH 7.5 and 8.0 resulted in 20% and 39% 
polykaryocytosis respective ly while treatments w ith  media at lower pH 
leve ls  produced no polykaryons. This re su lt indicated tha t the fusion 
prote in  o f BCV is  not dependent on ac id ic  conditions fo r  a c t iv ity .
V.C.4. Suppression o f fusion by anti-BCV antibody. The tryps in  
requirement fo r  BCV-induced ce ll fusion presented po ten tia l 
d i f f ic u l t ie s  fo r  our tests o f fusion suppression by a n t i-v ira l antibody 
because o f expected prote in  in te rac tions . Fusion suppression was 
therefore examined by two d if fe re n t procedures. Exposure a t 6 h post 
in fe c tio n  to  medium containing both tryp s in  and antibody reduced 
polykaryon formation by 50%. Greater reduction occurred when infected 
monolayers were pretreated with the antibody. Pre-incubation w ith the 
antibody before tryps in  treatment suppressed polykaryon formation by 
81% over s im ila r infected monolayers incubated w ith normal ra b b it serum 
IgG.
V.D. DISCUSSION.
Many enveloped viruses are capable o f inducing fusion o f cultured 
c e lls . The fusion a c t iv ity  o f alphaviruses, rhabdoviruses and 
myxoviruses s t r ic t ly  requires exposure o f the v iru s -c e ll complex to
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ac id ic  conditions (37, 43, 158, 159). Cell fusion can, however, be 
induced at physiological pH by paramyxoviruses, e ith e r among c e lls  
in fected at high m u lt ip l ic ity  (fusion from w ithout) or among infected 
c e lls  (fusion from w ith in ) (56, 152). A sp e c ific  g lycoprotein 
component (F) o f the paramyxovirus envelope is  known to  be involved in 
th is  membrane fusion a c t iv ity .  Fusion from w ithout occurs when the 
active form o f the F prote in is  expressed at the surface o f 
paramyxovirus-infected c e lls . The precursor form o f the F prote in  
which is  expressed at the surface o f nonpermissive c e lls  can be 
activated by treatment w ith an exogenous protease tha t cleaves the 
precursor at a sp e c ific  s ite  (119).
The suppression o f polykaryon formation by anti-BCV treatments o f 
in fected c e lls  indicates tha t coronaviral components were involved in 
c e ll fusion. Cells infected with the v irus fused together in s lig h t ly  
basic environments. In th is  respect, the fusogenic po ten tia l o f BCV 
resembles the paramyxovirus type o f fusion a c t iv ity .  The tryps in  
requirement o f the BCV fusion fac to r may involve a maturational 
cleavage o f a coronaviral component analogous to the F prote in  o f 
paramyxovirus. Although the fusion prote in  o f BCV has not been 
id e n tif ie d , recent work revealed tha t tryps in  treatment o f in fected 
c e lls  or v ir io n s  modifies several prote in components o f the BCV 
envelope (130, 161).
Trypsin exerted only a small e ffe c t on the y ie ld  o f in fectious 
v irus  in a single cycle o f v irus re p lica tio n  in  BFS c e lls . The 
hemagglutination t i t e r  increased sub s tan tia lly  a fte r  tryps in  treatment. 
This e ffe c t probably resulted from a disaggregation o f clumps o f
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noninfectious material because the in fec tious  v irus  y ie ld  did not r ise  
appreciably. A m p lifica tion  o f the v irus in fe c tio n  apparently does not 
account fo r  the required presence o f tryps in  fo r  fusion a c t iv ity .  
Trypsin m odifications o f BCV proteins may activa te  the v ira l fusion 
fa c to r w ithout producing a net change in the to ta l number o f in fectious 
p a rtic le s .
We id e n tif ie d  a period o f v irus  re p lica tio n  during which a 2 h 
tryps in  treatment would produce polykaryons. This b r ie f  treatment was 
used to avoid possible flu c tu a tions  in pH tha t might occur during a 
prolonged treatment. Infected cu ltures at 18 to  22 h were most 
susceptible to the b r ie f  tryp s in  treatment. This period begins at the 
observed onset o f fusion in  cu ltures treated continuously w ith tryp s in . 
The optimal time may be re la ted  to  the appearance o f a c r i t ic a l  leve l 
o f the BCV fusion prote ins at the ce ll surface. Trypsin treatments 
tha t began at 22 or 24 h produced fewer polykaryons, possib ly, because 
in s u ff ic ie n t time was ava ilab le  fo r  the fusing ce lls  to  coalesce and 
become v is ib ly  m ultinucleated.
Trypsin treatments during the time o f maximal su sce p tib lity  were 
e ffe c tive  only when media w ith pH leve ls o f 7.5 or 8.0 were used. To 
provide excess p ro te o ly tic  a c t iv ity ,  tryps in  was added at 1.0 ug per 
ml, a level 5 fo ld  greater than tha t needed fo r  ce ll fusion w ith 
continuous treatment at pH 7.8. The apparent ineffectiveness o f 
treatments at ac id ic  pH leve ls may be re lated to  the optimal pH range 
fo r  tryp s in  a c t iv ity .  Further investiga tion  is  necessary to determine 
the f u l l  range o f pH leve ls  at which the v ira l fusion prote in  is  
active . The resu lts  o f the experiments described here demonstrate tha t
BCV-induced c e ll fusion may occur at a lka line  pH leve ls . Therefore, 
the fusion prote in  o f th is  v irus is  not s t r ic t ly  dependent on pH leve ls 
o f 6 or less fo r  a c t iv ity .
The membrane fusion a c t iv ity  o f another coronavirus, mouse 
h e p a titis  v iru s , also occurs at neutral and s lig h t ly  a lka lin e  pH leve ls 
(138). In th is  respect, the coronaviruses appear to  resemble 
paramyxoviruses. Like these viruses, coronaviruses may be capable o f 
penetrating the host c e ll by fusion w ith the plasma membrane during 
in fectious entry.
CHAPTER V I: CHARACTERIZATION OF PLAQUES INDUCED BY BOVINE
CORONAVIRUS REPLICATION IN HRT-18 CELLS
VI.A . INTRODUCTION.
Cytopathic in te rac tions  o f bovine coronavirus w ith in te s tin a l 
c e lls  induce serious en te ric  disease in neonatal calves (33, 34, 54). 
These in te ractions have been studied in  several c e ll lin e s  (28, 135, 
144, 148). Some f ie ld  s tra ins  o f BCV, which fa i l  to  re p lica te  in 
other c e lls  can be cu ltiva te d  in HRT-18 c e lls , an in te s tin a l c e ll lin e  
derived from an adenocarcinoma (145). A large percentage o f the HRT-18 
c e lls  survive in the infected cu ltu re  even when v ira l cytopathic 
expression is  enhanced by the inclusion o f tryps in  in  the cu ltu re  
medium (130). The surviv ing c e lls  impart a ch a ra c te ris tic  tu rb id ity  to 
BCV-induced plaques.
This report describes scanning e lectron microscopic studies o f 
HRT-18 c e lls  res is tan t to the c y to ly t ic  e ffec ts  o f BCV. Apparent 
s im ila r it ie s  between these c e lls  and p e rs is te n tly  in fected HRT-18 
cu ltures were explored as w e ll.
VI.B. MATERIALS AND METHODS.
V I.B .l Cells and v iru s . Monolayers o f the human rec ta l tumor 
c e ll lin e  HRT-18 (145) were maintained in Dulbecco modified Eagle 
medium (DMEM) buffered w ith 44 mM NaHC03 and supplemented w ith 5% fe ta l 
c a lf  serum. Stock preparations o f the Mebus s tra in  L9 o f BCV (121,
131) were propagated in HRT-18 c e lls . Virus stocks were generated from 
c e lls  infected at a m u lt ip l ic ity  o f approximately 0.01 PFU per c e l l ,
77
78
incubated fo r  4-5 days at 37°C in serum-free DMEM and harvested by 
freeze-thawing. V ira l t i te r s  obtained in these preparations ranged 
from 106 to 107 PFU per m l.
V I.B .2. Plaque formation. Plaques were produced by c u lt iv a tio n  
o f the v irus  in monolayers o f HRT-18 c e lls  grown in 6-well tissue 
cu ltu re  dishes. The monolayers were incubated fo r  1 h at 37°C w ith 
d ilu te  suspensions o f the v irus in DMEM. The virus-adsorbed monolayers 
were washed w ith DMEM and covered w ith an overlay consisting o f DMEM 
w ith 0.6% agarose (Bethesda Research Laboratories) and 5 ug o f tryps in  
(D ifco Laboratories) per ml to enhance plaque formation (135). The 
plates were incubated fo r  2 to 4 d at 37°C in an atmosphere o f 5% C02. 
A fte r plaque development, the agarose overlay was removed from the 
cu ltures w ith a spatula. The monolayers were washed w ith PBS and fixed 
at 4°C fo r  30 min in 2% glutaraldehyde and 2% formaldehyde buffered 
w ith  0.1 M sodium cacodyl ate, pH 7.4.
V I.B .3. Hemadsorption by plaques. Cells in the plaques bearing 
v ira l hemagglutinin were id e n tif ie d  by th e ir  a b i l i t y  to adsorb 
erythrocytes to the ce ll surface. The agarose was removed at 60 h post 
in fe c tio n  from monolayers containing trypsin-enhanced plaques. The 
monolayers were washed three times w ith 0.01 M NaP04, 0.14 M NaCl at pH 
7.3 (PBS) to  remove the residual agarose, covered w ith a suspension o f 
6 X 106 mouse erythrocytes per ml in PBS, and incubated fo r  20 min at 
25°C to allow hemadsorption. The plaques were washed twice more w ith 
PBS to remove unbound erythrocytes and fixed  at 4°C fo r  30 min in 2%
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glutaraldehyde and 2% formaldehyde in  0.1 M sodium cacodyl ate bu ffe r, 
pH 7.4.
V I.B .4. Processing fo r  scanning e lectron microscopy. Monolayers 
fixed  fo r  scanning e lectron microscopy were washed in 0.1 M sodium 
cacodyl ate bu ffe r pH 7.4 and gently debased from the p la s tic  cu ltu re  
dishes w ith  a c e ll scraper. Areas o f in te re s t were cut from the 
monolayers w ith razor blades in to  segments approximately 5 mm2. The 
segments were incubated at 25°C in sodium cacodyl ate buffered solutions 
(pH 7) o f 1% osmium te trox ide  fo r  30 min, 1% tannic acid fo r  15 min, 
and again in 1% osmium te trox ide  fo r  15 min to  deposit a conductive 
coating on the ce ll surface. A fte r a f in a l rinse in  d is t i l le d  water, 
the samples were dehydrated in an alcohol series, c r i t ic a l  po in t dried 
from C02 in a c r i t ic a l  po in t drying aparatus (Poloron Equipment), 
mounted w ith tape on aluminum stubs, and coated w ith an a llo y  o f gold 
and palladium. The specimens were examined w ith a Cambridge S-150 
scanning electron microscope.
V I.B .4. Establishment o f p e rs is te n tly  in fected cu ltu res .
Monolayers o f HRT-18 c e lls  were grown in 25 cm2 flasks and inoculated 
w ith BCV at a m u lt ip l ic ity  o f approximately 0.01 PFU per c e ll to 
estab lish  pers is ten t in fe c tio n s . The cu ltures were incubated at 37°C 
fo r  6 to  12 days in serum-free medium. Trypsin (5 ug per ml) was added 
to the incubation medium o f certa in  cu ltures to enhance the cytopathic 
expression o f the v irus  during the establishment o f persistence. 
Supernatant f lu id  containing released v irus was harvested at weekly
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in te rva ls  fo r  plaque and hemadsorption assays and the cu ltu res were 
passaged and covered w ith DMEM supplemented w ith 5% fe ta l c a lf  serum.
V I.B .6. In d ire c t immunofluorescence. V ira l antigens in c e lls  
were traced w ith fluorescent antibody. The in fected monolayers were 
fixed  fo r  10 min in  4% formaldehyde in PBS w ith 0.005% CaCl2 and 0.11 M 
sucrose, permeabilized fo r  5 min w ith acetone at -20°C, incubated with 
ra bb it anti-BCV antibody, and reacted w ith goat a n ti- ra b b it antibody 
conjugated to fluoresce in  isothiocyanate. The preparations were viewed 
w ith a Le itz  fluorescent microscope using epifluorescence.
VI.C. RESULTS.
V I.C .l.  C haracteris tics o f v ira l plaques in  HRT-18 c e lls .  A
scanning e lectron micrograph depicting the apical surface o f an HRT-18 
c e ll monolayer is  i l lu s tra te d  in figu re  V I.1. The ep ithe liod  
appearance o f the confluent monolayer resulted from the close 
associations between the polygonal c e lls . The apical surface o f each 
c e ll was modified by a variab le  number o f small f i l i f o r m  m ic ro v il l i  
which were most numerous at the c e ll margins.
BCV-induced plaques at 3 days a fte r  p la tin g  in the presence o f 
tryp s in  were round, 1 to 2 mm-in-diameter, and had sharp edges.
In te r io r  regions o f the plaques were v is ib ly  tu rb id  except at tryps in  
concentrations higher than 5 ug per ml. The plaque margins were 
defined by a peripheral area o f extensive monolayer destruction tha t 
was revealed w ith the scanning electron microscope (FIG. V I.2 ). Many o f 
the c e lls  had detached from th is  marginal region leaving holes in the
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FIG. V I .1. Scanning electon micrographs o f a control monolayer o f
uninfected HRT-18 c e lls . (A) Cell borders are denoted by 
arrowheads. Bar = 10 urn. (B) M ic ro v il l i  at apical c e ll 
surface are f i l i f o r m .  Bar = 1 urn.
FIG. V I.2. Plaque induced by BCV re p lica tio n  fo r  60 h in HRT-18
monolayer. (A) Monolayer d is ruption  is  greatest at margin 
o f e n tire  plaque. Bar = 0.2 mm. (B) Depiction o f ce ll 
damage at the plaque margin. Bar = 10 urn. (C) A community 
o f undamaged c e lls  in plaque center. Bar = 10 urn.
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monolayer. The remaining c e lls  frequently  presented evidence o f v ira l 
cytopathic expression consisting o f ce ll rounding, plasma membrane 
damage, cy to lys is  and separation from adjo in ing c e lls . Monolayer 
damage was less prominent at in te r io r  areas o f the plaques where 
unaffected c e lls  predominated.
V I.C .2. Hemadsorption by plaques. Virus p a rtic le s , 100 to  130 
nm in s ize, where observed on the surfaces o f HRT-18 c e lls  in  infected 
monolayers (FIG. V I.3 ). The abundance o f v irus  p a rtic le s  varied widely 
from c e ll to  c e l l .  Cells in the in te r io r  regions o f plaques tha t were 
apparently unaffected by the v irus  in fe c tio n  genera lly possessed few or 
no surface p a rtic le s . We incubated plaques w ith erythrocytes to  tes t 
fo r  hemadsorption by these c e lls . Mouse erythrocytes were adsorbed to 
the m ic ro v il l i  o f ce lls  bearing surface v ir io n s  (FIG. V I.4). The 
v ir io n s  contributed to  e ry th rocy te -ce ll binding by bridging the 
membrane surfaces. Hemadsorbing c e lls  were most prominent near the 
plaque margin (FIG. V I.5A). This region o f in fected c e lls  extended at 
least 100 urn beyond the margin o f the plaque as defined by c e ll 
s tru c tu ra l damage. Damaged c e lls  were also present at in te r io r  regions 
o f the plaques but more than 90% o f the c e lls  were free o f erythrocytes 
(FIG. V I.5B). The hemadsorbing c e lls  frequently  had signs o f v ira l 
cytopathic e ffec ts  but the c e lls  which lacked v ira l hemagglutinin were 
s tru c tu ra lly  normal except fo r the some m icrov illous  c lu s te ring  which 
appeared to  be a response to the agarose overlay. Areas o f the 
monolayer at the plaque in te r io r  were less densely populated w ith 
c e lls .
FIG. V I.3. Adsorption o f v irus p a rtic le s  to  the c e ll surface. Virus 
p a rtic le s  (arrowheads) are abundant on c e ll (A) but less 
numerous on adjacent c e lls  (B,C). Bar = 1 urn.
FIG. V I.4. Erythrocyte bound to surface o f HRT-18 c e l l .  Note v irus 
p a rtic le s  (arrowheads) on erythrocyte, on c e ll surface and 
on m ic ro v illu s  linked to erythrocyte (arrow). Bar = 1 urn.
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FIG. V I .5. Plaque incubated with erythrocytes. (A) Erythrocytes bind 
to many ce lls  at plaque margin. (B) Central regions o f the 
plaque contain few ce lls  that have adsorbed erythrocytes 
(arrowhead). The s tru c tu ra l ly  damaged ce ll is  surrounded 
by normal c e l ls  that lack v ira l  hemagglutinin. Bars = 20 
urn.
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FIG. V I .6. Immunofluorescence o f v irus infected ce lls  in an HRT-18 
c a rr ie r  cu lture  at passage level 3.
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VI.C.3. HRT-18 cultures pe rs is ten tly  infected w ith BCV. We
inoculated monolayers o f HRT-18 ce lls  with BCV to establish 
pe rs is ten tly  infected cu ltures. Cytopathic expression o f the v irus 
consisted o f ce l l  rounding, monolayer vacuolization, and, in cultures 
incubated with tryps in , a l im ited  amount o f fusion. These e ffec ts  were 
maximal at 4 to 5 d post in fec tion  but the damaged monolayers remained 
nearly confluent. Monolayers incubated with tryps in  eventually 
detached from the p la s t ic  substrate.
Many ce lls  survived the i n i t i a l  in fec t ion . They rap id ly  
established confluent monolayers when the infected cultures were 
passaged and incubated with medium containing 5% serum to f a c i l i t a t e  
ce ll attachment and growth. The ce ll number increased at least 10 fo ld  
at each passage and v ira l  cytopathic expression was not read ily  
evident. These cultures carried the v irus in fec tion  fo r  8 passages at 
which time the experiment was concluded. Immunofluorescence analysis 
revealed tha t only 10 to  15% o f the ce lls  in these c a r r ie r  cultures 
contained v ira l  antigens (FIG. V I .6). The hemagglutinating a c t iv i t y  
varied from 4 to 64 in samples of cu lture supernatants and the 
in fe c t iv i t y  t i t e r s  ranged from 7.0 X 105 to  7.2 X 106 PFU per ml.
VI.D. DISCUSSION.
Cells o f the HRT-18 l in e  were very c losely associated in 
confluent monolayers. This association and the presence o f f i l i f o r m  
m ic ro v i l l i  on the apical surface re f le c t  the e p ith e l ia l  o r ig in  o f the 
ce ll l in e .  Scanning electron microscopy revealed a heterogenous
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mixture o f ce l ls  in the monolayer. C e l l- to -c e l l  d iv e rs ity  was apparent 
both in the number o f m ic ro v i l l i  at the apical surface and in the 
abundance o f coronavirions which adsorbed to the plasmalemma in 
infected cu ltures. The abundance o f surface-adsorbed coronavirions may 
re la te  to the concentration o f c e l lu la r  receptors fo r  the v irus . Both 
o f these features could be a function of the ce ll cycle or they may be 
cha rac te r is t ic  o f stable subpopulations in the cu ltu re . The 
heterogeneity o f the HRT-18 ce ll l in e  was recently studied with cloned 
sublines which d i f f e r  in th e ir  s u s c e p t ib i l i ty  to v i ra l  cytopathic 
expression (130).
The coronavirus m u lt ip l ied  in HRT-18 ce lls  and, in the presence 
o f tryps in , induced pronounced cytopathic changes in the monolayer. 
Plaques formed as the resu lt  o f v i ra l  destruction o f susceptible ce lls  
yet a residual tu rb id i ty  remained. The outer margin o f the plaque was 
defined by a peripheral zone o f monolayer d isruption . The central area 
was covered with a nearly confluent monolayer o f s tru c tu ra l ly  normal 
ce lls  tha t lacked v ira l  hemagglutinin. This plaque morphology may have 
developed by the fo llowing process: ( i )  A progession of in fections
which began with a single ce ll spread c e n tr i fu g a lly  to neighboring 
susceptible c e l ls .  These infected ce lls  suffered the e ffects  o f v ira l  
cytopathic expression, lysed, and u lt im ate ly  detached from the 
monolayer, ( i i )  Unaffected ce lls  in the plaque in te r io r  maintainted 
confluence by a reorganization o f th e ir  in te rc e l lu la r  junctions while 
the lysed ce lls  were released. Cell regrowth probably was not a fac to r 
in the maintenance o f th is  monolayer because the overlay lacked serum 
to support an increase in ce ll number, ( i i i )  Susceptible ce lls  at the
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periphery o f the plaque were more recently infected. Monolayer 
d is rup tion , therefore, was greatest at the peripheral zone o f the 
plaque because these c e l ls  had not yet d is in tegrated or detached. This 
margin represented the advancing fro n t o f  the spreading plaque.
Normal ce lls  coexisted with a small number o f infected c e l ls  at 
the plaque center in an association that was reminiscent o f a 
pers istent in fec t ion . We found that the v irus persisted in HRT-18 
cu ltu res. V ira l antigens were produced by a m inority  o f  the c e l ls  in 
c a r r ie r  cultures and progeny virus was released consis tently  fo r  at 
least 8 passages. Cell growth was affected l i t t l e  by the in fec t ion  and 
cytopathic expression o f the virus was minimal when the cu ltu re  medium 
was supplemented with serum. These pe rs is ten tly  infected cultures were 
eas ily  established and appeared to be stable.
Possible mechanisms involved in the establishment o f pers istent 
coronaviral in fections include conditional in terference by emerging 
temperature-sensitive or poorly growing mutants (6), the development of 
defective in te r fe r in g  v irus (84), and the production o f in te rfe ron  (5). 
Cell cycle-dependent varia tions in the expression o f c e l lu la r  receptors 
or organelles may place a temporal l im i t  on host s u s c e p t ib i l i ty  to BCV. 
This could allow continued HRT-18 ce ll growth and development o f 
daughter c e l ls  in the cu ltu re . We feel that c e l lu la r  determinants are 
probably an important fac to r in BCV persistence in these cultures 
because of the heterogeneity o f HRT-18 ce lls  and the presence of 
subpopulations with in t r in s ic  resistance to the v irus . Such c e l ls  have 
been found to be involved in the establishment o f a pers istent murine 
coronavirus in fec tion  on a subline of L c e l ls  (99).
CHAPTER V I I :  SUMMARY AND PERSPECTIVES OF INVESTIGATIONS
V II.A . SUMMARY OF FINDINGS.
The aim o f our investiga tion  was to analyze the morphogenetic 
aspects o f the membrane-associated stages o f BCV re p l ica t io n . We used 
morphological and physiological methods to analyze the entry o f BCV 
in to  HRT-18 c e l ls .  Immunoelectron microscopy revealed tha t many o f the 
v irus pa rt ic les  were endocytosed while other v ir io n s  fused with the 
c e ll  surface. The endosomal environment apparently fa i le d  to t r ig g e r  
v irus fusion along in t ra c e l lu la r  membranes and these pa rt ic les  
accumulated in secondary lysosomes. Endocytosis o f v irus p a rt ic les  
apparently represented an abortive in fec t ion . Our analyses o f the 
e ffec ts  o f lysosomotropic weak bases on BCV re p l ica t ion  indicated that 
an acid ic compartment is  not involved in BCV entry. Ammonium chloride 
treatment, which results  in a neu tra liza tion  o f the normally acid ic 
endosomal environment (93). was not in h ib i to ry  fo r  the f i r s t  hour of 
in fe c t io n . Suppression o f the in fec tion  by ammonium chloride would 
have supported the endocytic pathway fo r  in fectious entry by BCV. We 
concluded tha t in fectious entry by BCV does not involve the endocytic 
route thus implying tha t the ce lls  were infected by d ire c t  fusion o f 
the v ir io n  with the plasmalemma.
The v ira l  fusion fac to r was characterized by analyzing the 
conditions required fo r  BCV-induced polykaryocytosis. Virus infected 
c e l ls  formed polykaryons in neutral to s l ig h t ly  basic media containing 
t ryps in . This f ind ing is consistent with the hypothesis tha t BCV
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enters i t s  host ce ll by d ire c t  fusion with the plasmalemma under normal 
physiological conditions.
Simultaneous fusion o f large numbers o f v ir ions  with the surface 
membranes o f adjacent ce lls  may induce polykaryon formation from 
without. Cell fusion a lte rn a t iv e ly  may resu lt  from the action o f v ira l  
components expressed in the plasma membrane. We used immunoelectron 
microscopy to demonstrate tha t BCV antigens are expressed de novo in 
the plasma membrane o f infected ce lls  despite the in t ra c e l lu la r  mode o f 
coronaviral maturation. These antigens probably included the v ira l  
fusion fac to r because the structures were localized by the same 
antibody tha t causes a p a r t ia l  suppression o f polykaryon formation.
Cytopathic expression o f BCV rep l ica tion  resu lts  in plaques in 
monolayers o f HRT-18 c e l ls .  Scanning electon microscopy revealed that 
the ch a rac te r is t ic  tu rb id i ty  o f these plaques is  caused by the presence 
in the plaque in te r io r  o f s t ru c tu ra l ly  normal ce l ls  tha t lack v ira l  
hemagglutinin. These c e l ls  survived in the plaque in te r io r  while the 
infected ce l ls  lysed.
V II.B . CORONAVIRUS ENTRY.
The observation that many BCV pa rt ic les  were endocytosed by the 
ce ll was not an unexpected f ind ing . Endocytosis is a normal c e l lu la r  
process fo r  in te rn a liz ing  e x tra ce llu la r  material including inactive 
v irus p a rt ic le s . Unfavorable ra t ios  of physical v irus p a rt ic les  to 
in fectious p a rt ic les  pe rs is ten tly  burden morphological and biochemical 
studies o f the i n i t i a l  events o f v irus in fec tion  (32). The 
endocytosis o f  BCV probably represents c e l lu la r  scavenging o f
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"non-infectious" p a rt ic les . Since we were unable to f ind  c lear 
evidence o f fusion along in t ra c e l lu la r  endosomal membranes, we did not 
f ind  endocytosis relevant to BCV entry. An immunolocalization approach 
s im ila r  to ours was employed by Nemerow and Cooper (101) to study entry 
o f Epstein-Barr v irus in to  L c e l ls .  They c le a r ly  documented s ites  of 
v ira l  deenvelopment in in t ra c e l lu la r  vesicles with the immunogold 
technique. Fusion o f th is  herpesvirus with the surface membrane was 
not observed.
We found that ammonium chloride was not an e f f ic ie n t  in h ib i to r  o f 
the early stages o f BCV rep lica tion  but th is  resu lt  appears to c o n f l ic t  
with studies o f other coronaviruses. Recent investigations o f MHV 
rep l ica tion  c ited evidence of ammonium chloride suppression to support 
the conclusion tha t th is  coronavirus enters i t s  host c e l l  by the 
endocytic route (73, 98, 146). Krzystniak and Dupuy (73), fo r  example, 
described an in h ib ito ry  e ffec t o f ammonium chloride on MHV in fec tion  
but th e i r  experiments involved very low m u l t ip l ic i t ie s  o f in fec tion  (1 
X 10~5 to 2 X 10'4 PFU per c e l l ) .  The authors reported that the 
in h ib i to ry  e ffe c t o f ammonium chloride was eliminated when addition of 
the base was delayed u n t i l  3 h post in fec tion .
This lack o f in h ib it io n  with delayed treatment is  d i f f i c u l t  to 
understand i f  one considers that the low m u l t ip l ic i t y  o f in fec tion  
would allow m ultip le  cycles of in fections to amplify even small e ffects  
o f the base. Ammonium chloride in h ib it io n  o f MHV in fec tion  was also 
reported by Tooze and Tooze (146) but th is  e f fec t was seen at higher 
drug concentrations (30 mM) which may cause nonspecific c y to to x ic i ty .  
The apparent a n t iv ira l  a c t iv i ty  o f lysosomotrophic agents can resu lt
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from e ffects  other than a block in the transport o f  the v irus genome 
in to  the ce ll  cytoplasm (13).
Mizzen, et a l . (98) discovered that ammonium chloride delays 
rather than in h ib i ts  MHV in fec tion  and does not a f fec t the ultimate 
y ie ld  o f progeny v irus . They concluded that the primary e ffec t o f the 
base was to attenuate post fusion events by some undefined action on 
MHV uncoating during the eclipse phase. Our experiments, in comparison 
to the studies of MHV entry, involved cultures tha t were infected at 
high m u l t ip l ic i t y  to produce synchronous re p l ica t io n . We harvested the 
cultures at a time when virus y ie ld  would have included BCV production
that might have been delayed by treatment with the base.
These deviations in experimental design and in te rp re ta t ion  o f the 
resu lts  could explain the apparent c o n f l ic t  about the e ffec t o f 
ammonium chloride on coronavirus entry. MHV may in fac t d i f f e r  from 
BCV in i t s  response to the lysosomotroph but i t  is  d i f f i c u l t  to 
comprehend tha t d if fe re n t  coronaviruses enter the host ce ll by 
a lte rna tive  routes. I t  has been suggested that a number o f viruses are 
capable o f entering ce lls  by d ire c t fusion as well as the endocytic 
route. For example, electron microscopic studies revealed that the 
envelope o f vaccinia virus integrated with the L c e ll  plasma membrane 
(32) with endocytosis occurring as a la te r  event and possibly involving 
only incomplete p a rt ic les . Coronaviruses can, perhaps, in fec t host
c e lls  by e ithe r route but ce r ta in ly  one o f the a lte rna tives is  the
predominant mode o f entry fo r  a p a rt icu la r  v irus :host combination.
V irus-ce ll fusion during entry and virus-induced ce ll  fusion 
appear to be based on the same p r inc ip le  (68). A v irus dependent on
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the endocytic route of entry fo r  in fec t ion  would therefore be expected 
to have fusion proteins active at the ac id ic  environment encountered in 
the endosome. Cell fusion induced by BCV decidedly was not dependent 
on low pH conditions fo r  a c t iv i t y .  This phenomenon supports the 
hypothesis tha t BCV can in fe c t ce l ls  by d ire c t entry. The BFS l in e  was 
used fo r  th is  tes t because BCV in fec tion  o f these ce lls  resu lts  in 
countable polykaryons. Quantitation o f the extent o f fusion was not 
possible w ith the HRT-18 ce l l  l in e .  Large globular masses (presumably 
products o f ce ll fusion) are formed in infected HRT-18 cultures but the 
number of nuclei per globule is  not read ily  determined. The analysis 
o f BCV entry should be extended by a study o f the entry o f the virus 
in to  the BFS host c e l l .  C e l l - to -c e l l  fusion appears to occur more 
read ily  in these ce lls  so fusion o f v ir ions  with the plasma membrane 
may be more e f f ic ie n t  than with HRT-18 c e l ls .
V II.C . CELLULAR EXPRESSION OF CORONAVIRAL ANTIGENS.
Control o f v irus spread i_n vivo may involve immune recognition of 
v irus spec if ic  antigens on the ce ll  surface. The infected c e l ls  may 
then be removed p r io r  to the release of progeny v irus . Immune 
recognition and attack would be expected to remove BCV-infected 
enterocytes more e f f ic ie n t ly  i f  the v ira l  antigens were expressed in 
basolateral aspects o f the plasma membrane as w e ll.  Infected HRT-18 
ce lls  were found to express BCV antigens in the apical plasma membrane, 
but we were unable to determine i f  the antigens were also present at 
basolateral domains.
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The assembly o f many enveloped viruses is  assymetrical in 
polarized e p ith e l ia l  ce l ls  because the v ira l  envelope glycoproteins are 
segregated to e ithe r the apical or the basolateral membrane domains 
(113). Alonso-Caplen et a l . (2) reported tha t assembly o f the avian 
coronavirus IBV is susceptiole to in h ib i t io n  by monensin - -  an ionphore 
tha t se lec t ive ly  blocks transport o f  vesicular s tom atit is  virus 
glycoproteins to the basolateral membrane domain (1). Other than th is  
ind ication o f the involvement o f directed transport to  the basolateral 
membrane, the p o la r i ty  o f coronavirus release has not been determined. 
An important extension o f our work would be an analysis o f antigen 
expression in the basolateral and apical plasma membrane o f infected 
enterocytes o f calves inoculated with BCV.
A polyclonal mixture o f antibodies has p ractica l advantages fo r  
immunoelectron microscopy but the rabb it anti serum was unable to 
d is tingu ish  among the various antigenic components o f BCV. Further 
analysis o f v i ra l  antigen expression in BCV infected ce l ls  should 
involve a f f i n i t y  pu r i f ied  or monoclonal antibody probes tha t can detect 
ind iv idual v ira l  proteins. These investigations could determine i f  
p a r t ic u la r  proteins are expressed at re s tr ic te d  locations in the c e l l .  
Our attempts to loca lize  in t ra c e l lu la r  BCV antigens with post-embedment 
immunolabeling techniques were unsuccessful. An a lte rna tive  
technique--pre-embedment loca liza t io n  in ce l ls  permeabilized with 
saponin--may be more successful fo r  detecting the in t ra c e l lu la r  
locations of BCV proteins.
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V II .D . TRYPSIN ENHANCEMENT OF BCV PLAQUES.
Turbid plaques were formed in the presence o f tryps in  by BCV 
in fec tion  o f HRT-18 ce ll  monolayers. The cha rac te r is t ic  tu rb id i ty  
resulted from the survival o f s t ru c tu ra l ly  normal ce l ls  tha t were 
hemagglutinin negative. These ce lls  were found in a sub-confluent 
monolayer tha t apparently formed from a reorganization o f in t ra c e l lu la r  
junctions a f te r  infected c e l ls  d is integrated. This reorganization may 
be fa c i l i ta te d  by tryps in  action in weakening the in t ra c e l lu la r  
junctions. An e ffec t on the m ob ility  o f HRT-18 c e l ls  could augment 
other mechanisms that may be responsible fo r  tryps in  enhancement o f 
plaque formation such as activa tion  o f a v i ra l  fusion fac to r (130,
135).
V II.E . SIGNIFICANCE
BCV-induced e n te r i t is  in calves resu lts  p r im ar ily  from cytocidal 
e ffec ts  o f v irus rep lica tion  in susceptible enterocytes. 
Membrane-associated events of BCV rep lica tion  are important stages of 
the in fec t ion . These events are potentia l virulence factors because 
in teractions between the v irus and c e l lu la r  membranes contribute to 
ce ll  k i l l i n g  in many virus in fections (68). An improved understanding 
o f these events may, therefore, lead to practica l benefits in 
prevention and control o f coronaviral e n te r i t is .  These investigations 
are also s ig n if ic a n t as contributions to a basic understanding o f v ira l  
and c e l lu la r  in teractions.
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